Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Hamano E, et. al. (2005); Biochem. Biophys. Res. Commun.; 2005 Apr 22; 329(4) 1234-9
How Genetics Might Explain the Unusual Link Between Malaria and COVID-19. Rusmini M, et. al. (2021); Front Med (Lausanne); 2021 ; 8 650231. doi:10.3389/fmed.2021.650231
How Genetics Might Explain the Unusual Link Between Malaria and COVID-19. Rusmini M, et. al. (2021); Front Med (Lausanne); 2021 ; 8 650231. doi:10.3389/fmed.2021.650231
ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19? D'Amico S, et. al. (2021); Int J Mol Sci; 2021 Feb 08 ; 22 (4) . doi:10.3390/ijms22041705
Common variations in TERT-CLPTM1L locus are reproducibly associated with the risk of nasopharyngeal carcinoma in Chinese populations. Zhang Y, et. al. (2016); Oncotarget; 2016 Jan 05; 7(1) 759-70. doi:10.18632/oncotarget.6397
Common variations in TERT-CLPTM1L locus are reproducibly associated with the risk of nasopharyngeal carcinoma in Chinese populations. Zhang Y, et. al. (2016); Oncotarget; 2016 Jan 05; 7(1) 759-70. doi:10.18632/oncotarget.6397
Common variations in TERT-CLPTM1L locus are reproducibly associated with the risk of nasopharyngeal carcinoma in Chinese populations. Zhang Y, et. al. (2016); Oncotarget; 2016 Jan 05; 7(1) 759-70. doi:10.18632/oncotarget.6397
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
MBL2 polymorphisms in a variety of infectious diseases by the future studies.">The ambiguous role of mannose-binding lectin (MBL) in human immunity. Kalia N, et. al. (2021); Open Med (Wars); 2021 ; 16 (1) 299-310. doi:10.1515/med-2021-0239
Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19. Mustapha JO, et. al. (2021); Heliyon; 2021 Jan ; 7 (1) 05951. doi:10.1016/j.heliyon.2021.e05951
The role of Host Genetics in susceptibility to severe viral infections in humans and INSIGHTS into host genetics of severe COVID-19: A systematic review. Elhabyan A, et. al. (2020); Virus Res.; 2020 Sep 09 198163. doi:10.1016/j.virusres.2020.198163
Host genetic susceptibility to viral infections: the role of type I interferon induction. Bourdon M, et. al. (2020); Genes Immun; 2020 Nov 20 . doi:10.1038/s41435-020-00116-2
The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System. Świerzko AS, et. al. (2020); Front Immunol; 2020 ; 11 585243. doi:10.3389/fimmu.2020.585243
The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System. Świerzko AS, et. al. (2020); Front Immunol; 2020 ; 11 585243. doi:10.3389/fimmu.2020.585243
Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2. Mukherjee M, et. al. (2020); PLoS ONE; 2020 ; 15 (8) 0237559. doi:10.1371/journal.pone.0237559
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Ovsyannikova IG, et. al. (2020); Immunol. Rev.; 2020 07 ; 296 (1) 205-219. doi:10.1111/imr.12897
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry. Ragia G, et. al. (2020); Pharmacogenomics; 2020 Nov 27 . doi:10.2217/pgs-2020-0092
Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans. Xue X, et. al. (2021); Sci Rep; 2021 02 04 ; 11 (1) 3187. doi:10.1038/s41598-021-82938-2
Genetics Insight for COVID-19 Susceptibility and Severity: A Review. Fricke-Galindo I, et. al. (2021); Front Immunol; 2021 ; 12 622176. doi:10.3389/fimmu.2021.622176
Common variations in TERT-CLPTM1L locus are reproducibly associated with the risk of nasopharyngeal carcinoma in Chinese populations. Zhang Y, et. al. (2016); Oncotarget; 2016 Jan 05; 7(1) 759-70. doi:10.18632/oncotarget.6397
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. Long SW, et. al. (2020); mBio; 2020 Oct 30 ; 11 (6) . doi:10.1128/mBio.02707-20
The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues. Darbani B, et. al. (2020); Int J Environ Res Public Health; 2020 05 14 ; 17 (10) . doi:10.3390/ijerph17103433
ACE2", "polymorphism", "DPP4" and "telemedicine" was conducted on Pubmed and EMBASE till 7th August 2020. RESULT: Possible polymorphisms in ACE2 gene can play a role in influencing the virus entry in host body. Telemedicine can bring a new revolution for medical sector. CONCLUSION: COVID-19 severity is more heinous among diabetic population. So far, the in-silico studies involving human ACE2-viral Spike (S) interaction showed inconsistent predictions regarding some SNPs. But without actual in-vivo studies, a holistic understanding can't be established.">COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine. Sayed S, et. al. (2021); Prim Care Diabetes; 2021 02 ; 15 (1) 4-9. doi:10.1016/j.pcd.2020.08.018
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry. Ragia G, et. al. (2020); Pharmacogenomics; 2020 Nov 27 . doi:10.2217/pgs-2020-0092
Consensus and variations in cell line specificity among human metapneumovirus strains. Nao N, et. al. (2019); PLoS One. 2019 Apr 23;14(4):e0215822. doi: 10.1371/journal.pone.0215822.
Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database. Shibata Y, et. al. (2020); Lung Cancer; 2020 Dec 23 . doi:10.1016/j.lungcan.2020.12.016
Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. Hussain M, et. al. (2020); J. Med. Virol.; 2020 Apr 06 . doi:10.1002/jmv.25832
Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection. Wang J, et. al. (2020); J Gen Virol; 2020 09 ; 101 (9) 921-924. doi:10.1099/jgv.0.001452
A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations. Lee IH, et. al. (2020); Infect Genet Evol; 2020 11 ; 85 104507. doi:10.1016/j.meegid.2020.104507
MESH:C000657245 SARS-CoV-2 infection|Coronavirus disease 2019|novel coronavirus pneumonia|Covid-19|COVID-19MESH:C566236 RS ID Impact AA Change gnomADMESH:D001102 viral infection|virus infectionMESH:D001281 AFMESH:D003643 mortality|deathsMESH:D007239 infectedMESH:D011014 pneumoniaMESH:D011471 prostate and prostate cancer epitheliaMESH:D012131 respiratory failureMESH:D012141 upper respiratory tract infection
Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design. Sorokina M, et. al. (2020); Sci Data; 2020 09 16 ; 7 (1) 309. doi:10.1038/s41597-020-00652-6
Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism. Badraoui R, et. al. (2021); Molecules; 2021 Jan 28 ; 26 (3) . doi:10.3390/molecules26030673
Interacting Proteins, Polymorphisms and the Susceptibility of Animals to SARS-CoV-2. Hancock JT, et. al. (2021); Animals (Basel); 2021 Mar 12 ; 11 (3) . doi:10.3390/ani11030797
Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex. Chen Y, et. al. (2011); PLoS Pathog.; 2011 Oct; 7(10) 1002294. doi:10.1371/journal.ppat.1002294
Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design. Sorokina M, et. al. (2020); Sci Data; 2020 09 16 ; 7 (1) 309. doi:10.1038/s41597-020-00652-6
Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection. Klaassen K, et. al. (2020); Infect Genet Evol; 2020 10 ; 84 104498. doi:10.1016/j.meegid.2020.104498
MESH:C000657245 covid-19|SARS-CoV-2 infection|SARS-CoV infection|COVID-19MESH:C565965 TSI IBS CEU GBR FIN EAS SAS AFR AMR SRB|TSI IBS FIN GBR CEU EAS SAS AFR AMR PLGMESH:D000077277 esophageal squamous cell carcinomaMESH:D001102 viral diseases|viral infection|viral infectionsMESH:D003141 infectious diseasesMESH:D003550 cystic fibrosisMESH:D003643 mortality|deathMESH:D003922 type I diabetesMESH:D007239 infections|infection|infectedMESH:D009103 multiple sclerosisMESH:D010195 pancreatitisMESH:D011014 pneumoniaMESH:D012120 acute respiratory syndrome|acute respiratory syndrome coronavirus infectionMESH:D012140 respiratory diseaseMESH:D012598 sclerosisMESH:D015658 HIV infection|HIV-1 infection|human diseases or disordersMESH:D016098 GSDMESH:D018352 respiratory syndrome coronavirus infectionMESH:D030342 Mendelian diseasesMESH:D045169 severe acute respiratory syndromeMESH:D055744 invasive aspergillosis
Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression. Ulhaq ZS, et. al. (2021); Heliyon; 2021 Mar ; 7 (3) 06428. doi:10.1016/j.heliyon.2021.e06428
MESH:C000657245 SARS-CoV-2 infection|novel coronavirus pneumonia|COVID-19MESH:D000230 adenocarcinomaMESH:D001943 endometrial and breast cancer|breast carcinoma|breast cancer|Gynaecomastia and breast cancer|primary breast cancers|Breast cancerMESH:D002289 NSCLC|non-small cell lung cancerMESH:D002296 carcinosarcomaMESH:D003704 dementiaMESH:D003924 type 2 diabetes mellitusMESH:D004715 endometriosisMESH:D005128 ocular disease|ocular diseasesMESH:D005901 glaucomaMESH:D005902 open-angle glaucomaMESH:D006106 ovarian granulosa cell tumors|Ovarian Granulosa Cell TumorsMESH:D006177 Gynecomastia|gynecomastiaMESH:D007889 leiomyoma|leiomyoma TurkeyMESH:D008175 lung cancerMESH:D008949 malignant salivary gland tumorsMESH:D009369 tumor|malignancies|Cancer type Tumor|cancerous|aggressiveness of malignancies|cancer|cancers|carcinoma|cancer type/disease|neoplasms|multiple cancers|cancer aggressivenessMESH:D009798 intraocularMESH:D010051 ovaries|ovarian cancerMESH:D010300 Parkinson's diseaseMESH:D012162 degenerationMESH:D013274 gastric cancer|Gastric cancerMESH:D016889 endometrial carcinoma|Endometrial cancer|endometrial cancer|endometrial cancersMESH:D018239 seminomaMESH:D018567 male breast disorder|male breast cancerMESH:D024821 metabolic syndromeMESH:D062788 Adenomyosis|adenomyosis|leiomyoma and adenomyosisOMIM:181800 adolescent idiopathic scoliosis
Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection. Tu X, et. al. (2015); J. Infect.; 2015 Jul; 71(1) 101-9. doi:10.1016/j.jinf.2015.03.006
Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Ghafouri-Fard S, et. al. (2020); Biomed. Pharmacother.; 2020 Aug ; 128 110296. doi:10.1016/j.biopha.2020.110296
Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies. Dos Santos ACM, et. al. (2021); Infect Genet Evol; 2021 Apr 29 104846. doi:10.1016/j.meegid.2021.104846
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes. Sharma M, et. al. (2021); Int J Mol Sci; 2021 Jan 16 ; 22 (2) . doi:10.3390/ijms22020872
Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design. Sorokina M, et. al. (2020); Sci Data; 2020 09 16 ; 7 (1) 309. doi:10.1038/s41597-020-00652-6
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Ovsyannikova IG, et. al. (2020); Immunol. Rev.; 2020 07 ; 296 (1) 205-219. doi:10.1111/imr.12897
Whole Genome Identification of Potential G-Quadruplexes and Analysis of the G-Quadruplex Binding Domain for SARS-CoV-2. Zhang R, et. al. (2020); Front Genet; 2020 ; 11 587829. doi:10.3389/fgene.2020.587829
Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression. Narayanan K, et. al. (2015); Virus Res.; 2015 Apr 16; 20289-100. doi:10.1016/j.virusres.2014.11.019
MESH:C000657245 SARS-CoV infection|SARS-CoV and SARS-CoV-mt|SARS-CoV-mt-infected|CoV infection|SARS-CoV and SARS-CoV|CoV genera|SARS-CoV infectivity|SARS-CoV N antibody|chemokines Bat CoV|alpha-CoV, beta-CoV, gamma-CoV and delta-CoV|alpha-CoV and beta-CoV|SARS-CoV and MERS-CoV|SARS-CoV-infected|SARS-CoV and SARS-CoV-mt-infected|SARS-CoV-mt|SARS-CoV|CoV belonging|CoV|SARS-CoV- and SARS-CoV-mt-infected|CoV and beta-CoVMESH:C536751 SCoV-WTMESH:C538265 attenuated CoVMESH:C564422 respiratory syndrome coronavirus ADP-ribose-1"-phosphate dephosphorylationMESH:D001991 infectious bronchitisMESH:D003333 HCoV-229E, HCoV-HKU1MESH:D003924 HKU9-1, HKU9-2MESH:D004751 enteric diseasesMESH:D007239 mock-infected|infectionMESH:D007674 embryonic kidneyMESH:D011014 pneumoniaMESH:D012128 respiratory distress syndromeMESH:D012131 respiratory infection|viral respiratory disease|respiratory syndrome|respiratory syndrome CoV|respiratory diseaseMESH:D012497 beta-CoVMESH:D015430 SARS-CoV nsp1 gains accessMESH:D015658 virus infectionMESH:D016537 HKU9-1, belonging to beta-CoVBMESH:D018352 Coronavirus|respiratory syndrome coronavirus infection|coronavirus respiratory infections|SARS-coronavirus causes disease|respiratory syndrome CoV and Middle East respiratory syndrome CoV|Middle East respiratory syndrome CoV|coronavirus MHV-A59|Coronavirus Nonstructural|respiratory syndrome coronavirus Nsp15|coronavirus infections|respiratory syndrome coronavirus 3a|SARS Coronavirus|respiratory syndrome coronavirus|coronavirus|SARS-coronavirus-host|MERS|rhinovirus and coronavirusMESH:D018455 SARS-CoV SMESH:D042822 CoV genome|SARS-CoV genomeMESH:D045169 Coronaviruses post-SARS
Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2. Azad GK, et. al. (2021); PeerJ; 2021 ; 9 10666. doi:10.7717/peerj.10666
Coronavirus Endoribonuclease Activity in Porcine Epidemic Diarrhea Virus Suppresses Type I and Type III Interferon Responses. Deng X, et. al. (2019); J Virol. 2019 Apr 3;93(8). pii: JVI.02000-18. doi: 10.1128/JVI.02000-18. Print
The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. Ng MW, et. al. (2007); BMC Infect. Dis.; 2007 Jun 01; 750
Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies. Dos Santos ACM, et. al. (2021); Infect Genet Evol; 2021 Apr 29 104846. doi:10.1016/j.meegid.2021.104846
Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection. Wang Y, et. al. (2009); BMC Infect. Dis.; 2009 May 01; 951. doi:10.1186/1471-2334-9-51
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Ovsyannikova IG, et. al. (2020); Immunol. Rev.; 2020 07 ; 296 (1) 205-219. doi:10.1111/imr.12897
Mutational spectra of SARS-CoV-2 isolated from animals. Elaswad A, et. al. (2020); PeerJ; 2020 ; 8 10609. doi:10.7717/peerj.10609
MESH:C000656865 P P P L (2.7) P P P 199 P P PMESH:C000657245 COVID-2019|coronavirus disease 2019|SARS-CoV-2 infection|novel coronavirus disease|SARS-CoV-2 infections|2019-nCoV infection|nCoV-2019|COVID-19MESH:C536108 N N N TMESH:C562719 TNMESH:D000848 H H H Y (4.1) H H H|H H H H|H H H L|H H H H HMESH:D001260 T T T T T NC|L 5195 T T T I (4.1) T T|229 T T T|T T T TMESH:D003643 deathsMESH:D007239 infectedMESH:D011014 pneumoniaMESH:D012140 respiratory diseaseMESH:D015047 zoonotic|ZoonoticMESH:D018352 Middle East respiratory syndrome
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. Long SW, et. al. (2020); mBio; 2020 Oct 30 ; 11 (6) . doi:10.1128/mBio.02707-20
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. Elshazli RM, et. al. (2020); PLoS ONE; 2020 ; 15 (8) 0238160. doi:10.1371/journal.pone.0238160
Genetic justification of severe COVID-19 using a rigorous algorithm. Gavriilaki E, et. al. (2021); Clin Immunol; 2021 Apr 09 108726. doi:10.1016/j.clim.2021.108726
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19. Zhou Y, et. al. (2020); ChemRxiv; 2020 Jul 02 . doi:10.26434/chemrxiv.12579137.v1
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. Zhou Y, et. al. (2020); PLoS Biol; 2020 Nov 06 ; 18 (11) 3000970. doi:10.1371/journal.pbio.3000970
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19. Zhou Y, et. al. (2020); ChemRxiv; 2020 Jul 02 . doi:10.26434/chemrxiv.12579137.v1
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. Zhou Y, et. al. (2020); PLoS Biol; 2020 Nov 06 ; 18 (11) 3000970. doi:10.1371/journal.pbio.3000970
Alu retrotransposons and COVID-19 susceptibility and morbidity. Li M, et. al. (2021); Hum Genomics; 2021 Jan 04 ; 15 (1) 2. doi:10.1186/s40246-020-00299-9
Alu retrotransposons and COVID-19 susceptibility and morbidity. Li M, et. al. (2021); Hum Genomics; 2021 Jan 04 ; 15 (1) 2. doi:10.1186/s40246-020-00299-9
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations. Laamarti M, et. al. (2020); PLoS One; 2020 ; 15 (11) 0240345. doi:10.1371/journal.pone.0240345
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. Long SW, et. al. (2020); mBio; 2020 Oct 30 ; 11 (6) . doi:10.1128/mBio.02707-20
Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Hu Y, et. al. (2020); Acta Ophthalmol; 2020 May 14 . doi:10.1111/aos.14456
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Zubiaur P, et. al. (2020); Clin Transl Sci; 2020 Sep 16 . doi:10.1111/cts.12866
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs. Badary OA, et. al. (2021); Pharmacogenomics J; 2021 Feb 04 . doi:10.1038/s41397-021-00209-9
Pharmacogenetics Approach for the Improvement of COVID-19 Treatment. Fricke-Galindo I, et. al. (2021); Viruses; 2021 Mar 05 ; 13 (3) . doi:10.3390/v13030413
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome. Ramlall V, et. al. (2020); medRxiv; 2020 May 13 . doi:10.1101/2020.05.05.20092452
A double edged-sword - The Complement System during SARS-CoV-2 infection. Santiesteban-Lores LE, et. al. (2021); Life Sci; 2021 Feb 17 119245. doi:10.1016/j.lfs.2021.119245
SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection. Tsiftsoglou SA, et. al. (2021); Mol Immunol; 2021 Mar 26 . doi:10.1016/j.molimm.2021.03.021
Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function. Barrett CT, et. al. (2021); bioRxiv; 2021 Jan 25 . doi:10.1101/2021.01.24.428007
MESH:C000657245 SARS-CoV-2 infection|SARS-CoV-2 infected|CoV-2 infection|SARS-CoV-2-infected|coronavirus disease of 2019|SARS-CoV-2 fitness|COVID-19|hepatitis virus CoV SMESH:D001102 viral infectionMESH:D003110 colon carcinoma LoVo|colon carcinomaMESH:D003141 infectious diseasesMESH:D003643 deathMESH:D007239 Infection|infections|infection|infectedMESH:D007898 black arrowsMESH:D008175 Lung CancerMESH:D009102 multiple organ failureMESH:D009369 cancerMESH:D011014 Pneumonia|pneumoniaMESH:D012128 acute respiratory distress syndromeMESH:D013927 thrombosisMESH:D015047 zoonotic|Zoonotic Bat Coronavirus InfectionMESH:D018352 Coronavirus Tropism|respiratory syndrome coronavirus infection|Middle East respiratory syndrome coronavirus infection|respiratory syndrome coronavirus entry|coronavirus tropismMESH:D018455 pCAGGS-SMESH:D045464 Hendra Virus F
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy. Pillaiyar T, et. al. (2016); J. Med. Chem.; 2016 07 28; 59(14) 6595-628. doi:10.1021/acs.jmedchem.5b01461
The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif. Rohrbeck A, et. al. (2017); J. Biol. Chem.; 2017 10 27; 292(43) 17668-17680. doi:10.1074/jbc.M117.798231
The Nigral Coup in Parkinson's Disease by alpha-Synuclein and Its Associated Rebels. Sian-Hulsmann J, et. al. (2021); Cells; 2021 Mar 09 ; 10 (3) . doi:10.3390/cells10030598
MESH:C000657245 SARS-CoV-2 infection|SARS-CoV-2 infected|CoV-2 infected|SARS-CoV-2-infected|COVID 19|Covid-19|COVID-19|COVIDMESH:C535733 der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom.StructureMESH:C537475 Mitochondrial complex I deficiencyMESH:C562385 iron dyshomeostasisMESH:C566823 autosomal-dominant parkinsonismMESH:D000068079 motor dysfunction|motor abnormalitiesMESH:D000079225 StressMESH:D000080874 alpha-synucleinopathy|neurodegenerative synucleinopathiesMESH:D000370 hypogeusiaMESH:D000544 Alzheimer's disease|Alzheimer's disease brainsMESH:D000857 Hyposmia|hyposmiaMESH:D000860 hypoxiaMESH:D001102 viral infection|immunodeficiency virus-infected|immunodeficiency virus infection|viral infectionsMESH:D001284 atrophyMESH:D001480 extrapyramidal movement disordersMESH:D001927 encephalopathy|EncephalopathyMESH:D002534 hypoxic brain injuryMESH:D003141 LB diseaseMESH:D003643 Death|neurodegenerative cell deathMESH:D003693 deliriumMESH:D003704 dementiaMESH:D003711 demyelinating diseaseMESH:D003920 diabetesMESH:D004409 akinesiaMESH:D004660 encephalitisMESH:D004672 encephalitis BMESH:D005911 gliosisMESH:D006333 autonomic failureMESH:D006432 iron storage diseaseMESH:D006623 Verteilung von NoradrenalinMESH:D007153 deficiency|immunodeficiency virus/HIVMESH:D007239 Infections|Infection|infected|infectionMESH:D007249 inflammation|acute inflammationMESH:D008569 memory TMESH:D008659 metabolic diseasesMESH:D009069 Movement disordersMESH:D009127 Hypokinetic-rigid movement disordersMESH:D009336 Tumor necrosisMESH:D009410 neuronal loss|SN neuronal loss|neuronal dysfunction|neuronal necrosis|neuronal cell death|SN neuronal degeneration|neuronal damageMESH:D009421 neurological defectsMESH:D009422 neurological symptomsMESH:D009443 Lewy neuritisMESH:D009461 motor deficits|dysfunctionalMESH:D010300 Parkinson's Disease|idiopathic Parkinson's disease|PD brains|Parkinson's|PD|parkinsonsim and Parkinson's disease|Parkinson's disease|familial Parkinson's disease|Parkinson disease|PD-like injury|Lewy bodies of Parkinson disease|Parkinson Disease|neurodegenerative disorder Parkinson's disease|Idiopathic Parkinson's disease|Parkinson's disease-a multifactorial neurodegenerative disorder|autosomal dominant PDMESH:D010301 encephalitis lethargica|encephalitic parkinsonism|postencephalitic parkinsonism|Encephalitis lethargicaMESH:D010302 Parkinson|parkinsonismMESH:D010859 pigmentationMESH:D012120 respiratory syndromeMESH:D012128 acute respiratory distress syndrome|ARDSMESH:D012162 degeneration via microgliosisMESH:D012791 systems atrophies|degeneration in multiple systems atrophyMESH:D013167 SpondyloarthritisMESH:D013226 status epilepticusMESH:D013651 mitochondriopathy, dysfunction of metal homeostasisMESH:D014202 tremorMESH:D015526 HIV dementia|Parkinsonism in HIV dementia|AIDS Dementia ComplexMESH:D015658 HIV-infected|HIV infectionMESH:D016464 lysosomal disordersMESH:D018352 coronavirus diseaseMESH:D018476 bradykinesiaMESH:D019636 neurodegenerative disorders|neurodegenerative maladies|Neurodegeneration|neurodegenerative diseases|neurodegeneration|SN neurodegeneration|neurodegenerative disorderMESH:D020031 Epstein-BarrMESH:D020258 neurotoxic|neurotoxicityMESH:D020271 Neurological DiseasesMESH:D020521 strokesMESH:D020734 parkinsonian deficits|autosomal recessive parkinsonism|parkinsonian brains|Parkinson-like syndrome|parkinsonian|parkinsonian brainMESH:D020961 Lewy body disease|Lewy body diseasesMESH:D028361 mitochondrial deficits|mitochondrial dysfunction|Mitochondrial dysfunctionMESH:D030342 genetic defect|genetic abnormality|neuropathogenesis of the disorderMESH:D034721 system dysfunctionMESH:D057165 proteostasisMESH:D064420 cytotoxicity|toxicityMESH:D065703 Neuronal ApoptosisOMIM:256040 proteasomal dysfunction
Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Li L, et. al. (2020); Brain Behav Immun; 2020 Oct 08 . doi:10.1016/j.bbi.2020.10.007
MESH:C000657245 SARS-CoV-2 infection|SARS-CoV-2-infected|coronavirus disease-2019|COVID-19|COVID19 InfectMESH:C535882 JohnsonMESH:C536050 OGDMESH:C536395 HSV encephalitis|HSV-1 infection|HSV-2 infectionMESH:C538265 IC Attenuates Reactive AstrogliosisMESH:C566985 brain atrophyMESH:D000067390 ColdMESH:D000070642 Traumatic Brain Injury|traumatic brain Injury|traumatic brain injuryMESH:D000080874 synucleinopathies|synucleinopathyMESH:D000163 AIDS brains|acquired immunodeficiency syndrome|AIDSMESH:D000370 hypogeusia/hyposmia|ageusiaMESH:D000544 Alzheimer|Alzheimer's disease|Alzheimer disease brains|Alzheimer's Disease|AD|Alzheimer diseaseMESH:D000690 amyotrophic lateral sclerosis|Amyotrophic lateral sclerosisMESH:D000783 spinal cord ischemiaMESH:D000857 anosmiaMESH:D001102 Neurotropic virus infections|Virus Infections|virus-infected|Viral diseases|viral infections|Infectious Diseases Viral infection|Viral infections|Virus Infection|virus infection|viral infectionMESH:D001327 autoimmunityMESH:D001424 bacterial infections|astroglial TLRs in bacterial infections|bacterial infectionMESH:D001480 axonal damageMESH:D001523 behavioral deficits|neuro-psychiatric disordersMESH:D001925 brain damage|Brain DamageMESH:D001927 encephalopathyMESH:D001930 ischemic brain injuryMESH:D002006 Brucella infections|Brucella abortus infection|Brucella infection|brucellosis increasesMESH:D002493 astroglial TLRs in CNS disease|CNS dysfunction|CNS injury and disease|Traumatic CNS injury|CNS injury|CNS disorders|traumatic CNS injuries|astroglial TLRs to CNS injuries|CNS disease and injuryMESH:D002494 central nervous system infection|astroglial TLRs in CNS infections|CNS infections|CNS infections via involvement of TLRs|Infections of the Central Nervous System|CNS infection|central nervous system infectionsMESH:D002534 hypoxic injury|hypoxic damageMESH:D002544 ischemic focal stroke|artery ischaemic strokeMESH:D002545 Cerebral Ischemia|cerebral ischemia|brain ischemiaMESH:D002561 cerebrovascular diseaseMESH:D003072 memory loss and cognitive deficits|cognitive impairment|Cognitive impairment|HIV infection of the brain impairs cognitiveMESH:D003141 cardiorespiratory disease|infectious diseasesMESH:D003643 mortality|Death|death|Mortality and DiseaseMESH:D003711 demyelination|chronic demyelinating diseaseMESH:D004194 Damage and Lethal Disease|injuries and diseasesMESH:D004487 swelling|ischemia Astrocyte swelling/edema|edemaMESH:D004660 meningitis/encephalitis|Encephalitis|encephalitisMESH:D004673 acute disseminated encephalomyelitisMESH:D004679 encephalomyelitisMESH:D005911 white matter gliosis|gliosisMESH:D005935 Tumor Necrosis Factor-alphaMESH:D006313 Neurosensory dysfunctionMESH:D006333 heart failureMESH:D006816 HD|Huntington's disease|Huntington diseaseMESH:D006984 hypertrophyMESH:D007027 hypothalamicMESH:D007153 immunodeficiency virus|TLR4 deficiency|TLR3 Deficiency|TLR deficiency|TLR3 deficiencyMESH:D007154 immune system failureMESH:D007239 Infections|infection|Infection|Infected|life-long infection|infections|infected|neuronal infectionMESH:D007249 inflammation|RAGE-TLR Crosstalk Sustains Chronic Inflammation|inflammatory disease|InflammationMESH:D007511 ischemicMESH:D008107 ALS-like diseaseMESH:D008113 familial ALSMESH:D008581 meningitisMESH:D008831 microcephaly and congenital brain anomaliesMESH:D009103 multiple sclerosis|multiple sclerosis brainMESH:D009336 necroticMESH:D009369 cancer|TumorMESH:D009410 neuronal death|neuronal degeneration|neuronal loss|neuronal injury|neuronal damage|neuronal toxicity|axonal degenerationMESH:D009422 neurological symptoms|nervous system injury and disease|neurological dysfunction|neurological disorders|Non-Cell-Autonomous Neurodegeneration|Neurological DisordersMESH:D009437 neuropathic painMESH:D009461 degeneration and dysfunction|neurological deficitsMESH:D010146 painMESH:D010243 paralysisMESH:D010300 Parkinson's Disease|Neuropathology of Parkinson disease|PD|Abeta Neuronal death Parkinson's Disease|Parkinson's disease|Parkinson's disease brain|Parkinson's disease brainsMESH:D010301 encephaliticMESH:D011273 prolongs neuroinflammationMESH:D011537 itchMESH:D012131 respiratory failureMESH:D012598 sclerosis|SclerosisMESH:D012640 seizuresMESH:D012769 heat shock proteinsMESH:D012892 glucose deprivationMESH:D013118 spinal cord astrocytic swellingMESH:D013119 spinal cord injuries|spinal cord injuryMESH:D013120 glia of ALS spinal cordMESH:D014901 WNV infectionsMESH:D014947 injuriesMESH:D015047 zoonoticMESH:D015427 spinal cord ischemia-reperfusion injuryMESH:D015526 AIDS dementiaMESH:D015658 HIV-infected|HIV infection|HIV-1 infection|immunodeficiency virus type 1 infectionMESH:D016263 HIV-1-associated neuropathologyMESH:D016920 bacterial meningitisMESH:D017827 JosephMESH:D018177 flavivirus infections|flavivirus infectionMESH:D018352 coronavirus infections|MERS|coronavirus infection|Middle East Respiratory Syndrome|Middle East respiratory syndrome coronavirus infectionMESH:D018980 WilliamsMESH:D019636 Neurodegeneration|injury and neurodegenerative diseases|neurodegenerative diseases|neurodegeneration|Neurodegenerative diseases|neurodegenerative disorders|astroglial TLRs to neurodegenerative diseases|neurodegenerative disorder|neurodegenerative diseaseMESH:D019965 neurocognitive impairmentMESH:D020258 astrocyte neurotoxicity|Neurotoxic|neurotoxicMESH:D020271 neurological diseaseMESH:D020295 degeneration of ventral midbrainMESH:D020521 stroke|StrokeMESH:D045169 Severe Acute Respiratory Syndrome Coronavirus InfectionMESH:D056486 hepatitis coronavirusMESH:D056784 white matter lesionsMESH:D064420 toxicity
Diversity and versatility of p38 kinase signalling in health and disease. Canovas B, et. al. (2021); Nat Rev Mol Cell Biol; 2021 Jan 27 . doi:10.1038/s41580-020-00322-w
Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery. Qian L, et. al. (2021); Int J Mol Sci; 2021 Jan 26 ; 22 (3) . doi:10.3390/ijms22031203
The Nigral Coup in Parkinson's Disease by alpha-Synuclein and Its Associated Rebels. Sian-Hulsmann J, et. al. (2021); Cells; 2021 Mar 09 ; 10 (3) . doi:10.3390/cells10030598
MESH:C000657245 SARS-CoV-2 infection|SARS-CoV-2 infected|CoV-2 infected|SARS-CoV-2-infected|COVID 19|Covid-19|COVID-19|COVIDMESH:C535733 der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom.StructureMESH:C537475 Mitochondrial complex I deficiencyMESH:C562385 iron dyshomeostasisMESH:C566823 autosomal-dominant parkinsonismMESH:D000068079 motor dysfunction|motor abnormalitiesMESH:D000079225 StressMESH:D000080874 alpha-synucleinopathy|neurodegenerative synucleinopathiesMESH:D000370 hypogeusiaMESH:D000544 Alzheimer's disease|Alzheimer's disease brainsMESH:D000857 Hyposmia|hyposmiaMESH:D000860 hypoxiaMESH:D001102 viral infection|immunodeficiency virus-infected|immunodeficiency virus infection|viral infectionsMESH:D001284 atrophyMESH:D001480 extrapyramidal movement disordersMESH:D001927 encephalopathy|EncephalopathyMESH:D002534 hypoxic brain injuryMESH:D003141 LB diseaseMESH:D003643 Death|neurodegenerative cell deathMESH:D003693 deliriumMESH:D003704 dementiaMESH:D003711 demyelinating diseaseMESH:D003920 diabetesMESH:D004409 akinesiaMESH:D004660 encephalitisMESH:D004672 encephalitis BMESH:D005911 gliosisMESH:D006333 autonomic failureMESH:D006432 iron storage diseaseMESH:D006623 Verteilung von NoradrenalinMESH:D007153 deficiency|immunodeficiency virus/HIVMESH:D007239 Infections|Infection|infected|infectionMESH:D007249 inflammation|acute inflammationMESH:D008569 memory TMESH:D008659 metabolic diseasesMESH:D009069 Movement disordersMESH:D009127 Hypokinetic-rigid movement disordersMESH:D009336 Tumor necrosisMESH:D009410 neuronal loss|SN neuronal loss|neuronal dysfunction|neuronal necrosis|neuronal cell death|SN neuronal degeneration|neuronal damageMESH:D009421 neurological defectsMESH:D009422 neurological symptomsMESH:D009443 Lewy neuritisMESH:D009461 motor deficits|dysfunctionalMESH:D010300 Parkinson's Disease|idiopathic Parkinson's disease|PD brains|Parkinson's|PD|parkinsonsim and Parkinson's disease|Parkinson's disease|familial Parkinson's disease|Parkinson disease|PD-like injury|Lewy bodies of Parkinson disease|Parkinson Disease|neurodegenerative disorder Parkinson's disease|Idiopathic Parkinson's disease|Parkinson's disease-a multifactorial neurodegenerative disorder|autosomal dominant PDMESH:D010301 encephalitis lethargica|encephalitic parkinsonism|postencephalitic parkinsonism|Encephalitis lethargicaMESH:D010302 Parkinson|parkinsonismMESH:D010859 pigmentationMESH:D012120 respiratory syndromeMESH:D012128 acute respiratory distress syndrome|ARDSMESH:D012162 degeneration via microgliosisMESH:D012791 systems atrophies|degeneration in multiple systems atrophyMESH:D013167 SpondyloarthritisMESH:D013226 status epilepticusMESH:D013651 mitochondriopathy, dysfunction of metal homeostasisMESH:D014202 tremorMESH:D015526 HIV dementia|Parkinsonism in HIV dementia|AIDS Dementia ComplexMESH:D015658 HIV-infected|HIV infectionMESH:D016464 lysosomal disordersMESH:D018352 coronavirus diseaseMESH:D018476 bradykinesiaMESH:D019636 neurodegenerative disorders|neurodegenerative maladies|Neurodegeneration|neurodegenerative diseases|neurodegeneration|SN neurodegeneration|neurodegenerative disorderMESH:D020031 Epstein-BarrMESH:D020258 neurotoxic|neurotoxicityMESH:D020271 Neurological DiseasesMESH:D020521 strokesMESH:D020734 parkinsonian deficits|autosomal recessive parkinsonism|parkinsonian brains|Parkinson-like syndrome|parkinsonian|parkinsonian brainMESH:D020961 Lewy body disease|Lewy body diseasesMESH:D028361 mitochondrial deficits|mitochondrial dysfunction|Mitochondrial dysfunctionMESH:D030342 genetic defect|genetic abnormality|neuropathogenesis of the disorderMESH:D034721 system dysfunctionMESH:D057165 proteostasisMESH:D064420 cytotoxicity|toxicityMESH:D065703 Neuronal ApoptosisOMIM:256040 proteasomal dysfunction
360" days post-injection (dpi), pathological alphaSyn conversion or clinical symptoms in transgenic TgM83+/- mice hemizygously expressing mutated (A53T) human alphaSyn (Prusiner et al. 2015, PNAS 112:E5308-E5317). To advance the assessment of possible alphaSynPD hazards by providing further data, we examined neuropathological and clinical effects upon i.c. transmission of brain, stomach wall and muscle tissue as well as blood from PD patients in TgM83+/- mice up to 612 dpi. This revealed a subtle, yet distinctive stimulation of localized alphaSyn aggregation in the somatodendritic compartment and dystrophic neurites of individual or focally clustered cerebral neurons after challenge with brain and stomach wall homogenates. No such effect was observed with transmitted blood or homogenized muscle tissue. The detected stimulation of alphaSyn aggregation was not accompanied by apparent motor impairments or overt neurological disease in TgM83+/- mice. Our study substantiated that transmitted alphaSynPD seeds, including those from the stomach wall, are able to propagate in new mammalian hosts. The consequences of such propagation and potential safeguards need to be further investigated.">Transmissible alpha-synuclein seeding activity in brain and stomach of patients with Parkinson's disease. Thomzig A, et. al. (2021); Acta Neuropathol; 2021 Apr 24 . doi:10.1007/s00401-021-02312-4
MESH:C000598645 spheroid-like alphaSyn immunolabellingMESH:C000657245 SARS-CoV-2-infected|Covid-19MESH:C536778 SCDMESH:C537412 substantia nigra reticulataMESH:C564858 PK-resistant alphaSyn depositsMESH:D000068079 motor impairmentsMESH:D000079822 cerebral alphaSyn depositsMESH:D000080874 synucleinopathyMESH:D000544 Alzheimer's disease|Alzheimer's|Alzheimer's transfer|AD|Alzheimer diseaseMESH:D001259 ataxiaMESH:D001284 atrophyMESH:D001791 alphaSyn aggregation|hMW alphaSynPD aggregates|immunolabelling of alphaSynPD aggregates|cerebral alphaSyn aggregation|immunolabelling of hMW alphaSynPD aggregates|cerebral aggregation|subtle cerebral aggregation|alphaSynPD aggregates|aggregated alphaSynPDMESH:D001796 cerebral protein aggregationMESH:D001927 encephalopathiesMESH:D002543 intracerebralMESH:D002544 ischemic strokeMESH:D003643 died|deathMESH:D003704 dementiaMESH:D006402 cerebral protein aggregation disease|alphaSyn aggregation disease|alphaSyn aggregation diseases|protein aggregation diseasesMESH:D006623 Nachweis der Freiheit von einer KrankheitMESH:D006816 HDMESH:D007049 iatrogenic alphaSynPDMESH:D007239 infection|infectedMESH:D009069 movement impairment|movement disorderMESH:D009207 MJMESH:D009422 neurological impairments or disease|neurological impairments|neurological symptomsMESH:D010243 paralysisMESH:D010300 idiopathic Parkinson's disease|NBH Non-PD|PD brains|Parkinson disease|Parkinson s disease|PD|Parkinson's disease|neuropathological hallmark of Parkinson's diseaseMESH:D010302 Parkinson|parkinsonismMESH:D014202 tremorMESH:D015431 weight lossMESH:D016472 motor diseaseMESH:D016657 cerebral amyloid angiopathyMESH:D018376 apathy or abnormalitiesMESH:D019636 nigrostriatal neurodegeneration|neurodegenerative protein aggregation disorders|neurodegenerative diseases|neurodegenerative protein aggregation disease|neurodegeneration|neurodegenerative diseaseMESH:D020271 Neurological disease|neurological diseaseMESH:D020961 Lewy body diseasesMESH:D053632 LB-linked alphaSynPDMESH:D058225 dystrophic neurite|somatodendritic/dystrophic neurite|neuritic alphaSyn|dystrophic neuritesMESH:D060825 impairments
The Nigral Coup in Parkinson's Disease by alpha-Synuclein and Its Associated Rebels. Sian-Hulsmann J, et. al. (2021); Cells; 2021 Mar 09 ; 10 (3) . doi:10.3390/cells10030598
MESH:C000657245 SARS-CoV-2 infection|SARS-CoV-2 infected|CoV-2 infected|SARS-CoV-2-infected|COVID 19|Covid-19|COVID-19|COVIDMESH:C535733 der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom.StructureMESH:C537475 Mitochondrial complex I deficiencyMESH:C562385 iron dyshomeostasisMESH:C566823 autosomal-dominant parkinsonismMESH:D000068079 motor dysfunction|motor abnormalitiesMESH:D000079225 StressMESH:D000080874 alpha-synucleinopathy|neurodegenerative synucleinopathiesMESH:D000370 hypogeusiaMESH:D000544 Alzheimer's disease|Alzheimer's disease brainsMESH:D000857 Hyposmia|hyposmiaMESH:D000860 hypoxiaMESH:D001102 viral infection|immunodeficiency virus-infected|immunodeficiency virus infection|viral infectionsMESH:D001284 atrophyMESH:D001480 extrapyramidal movement disordersMESH:D001927 encephalopathy|EncephalopathyMESH:D002534 hypoxic brain injuryMESH:D003141 LB diseaseMESH:D003643 Death|neurodegenerative cell deathMESH:D003693 deliriumMESH:D003704 dementiaMESH:D003711 demyelinating diseaseMESH:D003920 diabetesMESH:D004409 akinesiaMESH:D004660 encephalitisMESH:D004672 encephalitis BMESH:D005911 gliosisMESH:D006333 autonomic failureMESH:D006432 iron storage diseaseMESH:D006623 Verteilung von NoradrenalinMESH:D007153 deficiency|immunodeficiency virus/HIVMESH:D007239 Infections|Infection|infected|infectionMESH:D007249 inflammation|acute inflammationMESH:D008569 memory TMESH:D008659 metabolic diseasesMESH:D009069 Movement disordersMESH:D009127 Hypokinetic-rigid movement disordersMESH:D009336 Tumor necrosisMESH:D009410 neuronal loss|SN neuronal loss|neuronal dysfunction|neuronal necrosis|neuronal cell death|SN neuronal degeneration|neuronal damageMESH:D009421 neurological defectsMESH:D009422 neurological symptomsMESH:D009443 Lewy neuritisMESH:D009461 motor deficits|dysfunctionalMESH:D010300 Parkinson's Disease|idiopathic Parkinson's disease|PD brains|Parkinson's|PD|parkinsonsim and Parkinson's disease|Parkinson's disease|familial Parkinson's disease|Parkinson disease|PD-like injury|Lewy bodies of Parkinson disease|Parkinson Disease|neurodegenerative disorder Parkinson's disease|Idiopathic Parkinson's disease|Parkinson's disease-a multifactorial neurodegenerative disorder|autosomal dominant PDMESH:D010301 encephalitis lethargica|encephalitic parkinsonism|postencephalitic parkinsonism|Encephalitis lethargicaMESH:D010302 Parkinson|parkinsonismMESH:D010859 pigmentationMESH:D012120 respiratory syndromeMESH:D012128 acute respiratory distress syndrome|ARDSMESH:D012162 degeneration via microgliosisMESH:D012791 systems atrophies|degeneration in multiple systems atrophyMESH:D013167 SpondyloarthritisMESH:D013226 status epilepticusMESH:D013651 mitochondriopathy, dysfunction of metal homeostasisMESH:D014202 tremorMESH:D015526 HIV dementia|Parkinsonism in HIV dementia|AIDS Dementia ComplexMESH:D015658 HIV-infected|HIV infectionMESH:D016464 lysosomal disordersMESH:D018352 coronavirus diseaseMESH:D018476 bradykinesiaMESH:D019636 neurodegenerative disorders|neurodegenerative maladies|Neurodegeneration|neurodegenerative diseases|neurodegeneration|SN neurodegeneration|neurodegenerative disorderMESH:D020031 Epstein-BarrMESH:D020258 neurotoxic|neurotoxicityMESH:D020271 Neurological DiseasesMESH:D020521 strokesMESH:D020734 parkinsonian deficits|autosomal recessive parkinsonism|parkinsonian brains|Parkinson-like syndrome|parkinsonian|parkinsonian brainMESH:D020961 Lewy body disease|Lewy body diseasesMESH:D028361 mitochondrial deficits|mitochondrial dysfunction|Mitochondrial dysfunctionMESH:D030342 genetic defect|genetic abnormality|neuropathogenesis of the disorderMESH:D034721 system dysfunctionMESH:D057165 proteostasisMESH:D064420 cytotoxicity|toxicityMESH:D065703 Neuronal ApoptosisOMIM:256040 proteasomal dysfunction
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Zubiaur P, et. al. (2020); Clin Transl Sci; 2020 Sep 16 . doi:10.1111/cts.12866
Multifactorial Rare Diseases: Can Uncertainty Analysis Bring Added Value to the Search for Risk Factors and Etiopathogenesis? Taruscio D, et. al. (2021); Medicina (Kaunas); 2021 Jan 28 ; 57 (2) . doi:10.3390/medicina57020119
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Zeberg H, et. al. (2021); Proc Natl Acad Sci U S A; 2021 Mar 02 ; 118 (9) . doi:10.1073/pnas.2026309118
Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation. Dai Y, et. al. (2021); bioRxiv; 2021 Feb 19 . doi:10.1101/2021.02.17.431554
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Nakanishi T, et. al. (2021); medRxiv; 2021 Mar 12 . doi:10.1101/2021.03.07.21252875
The landscape of host genetic factors involved in infection to common viruses and SARS-CoV-2. Kachuri L, et. al. (2020); medRxiv; 2020 May 30 . doi:10.1101/2020.05.01.20088054
Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification. Grolmusz VK, et. al. (2021); Front Immunol; 2021 ; 12 653489. doi:10.3389/fimmu.2021.653489
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches. Mozzi A, et. al. (2017); Infect. Genet. Evol.; 2017 Sep 22. doi:10.1016/j.meegid.2017.09.028
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control. Salpini R, et. al. (2021); J Antimicrob Chemother; 2021 01 19 ; 76 (2) 396-412. doi:10.1093/jac/dkaa444
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Zubiaur P, et. al. (2020); Clin Transl Sci; 2020 Sep 16 . doi:10.1111/cts.12866
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Zubiaur P, et. al. (2020); Clin Transl Sci; 2020 Sep 16 . doi:10.1111/cts.12866
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design. Sorokina M, et. al. (2020); Sci Data; 2020 09 16 ; 7 (1) 309. doi:10.1038/s41597-020-00652-6
Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19. Roy Wong LY, et. al. (2021); bioRxiv; 2021 Apr 21 . doi:10.1101/2021.04.20.440676
DNA genotyping of the ABO gene showed a significant association of the A-group (A1/A2 variants) with severe COVID-19. Gómez J, et. al. (2021); Eur J Intern Med; 2021 Feb 25 . doi:10.1016/j.ejim.2021.02.016
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Development and application of sensitive, specific and rapid CRISPR-Cas13-based diagnosis. Gao D, et. al. (2021); J Med Virol; 2021 Feb 18 . doi:10.1002/jmv.26889
Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. Hosseini Rad Sm A, et. al. (2020); Int J Mol Sci; 2020 Jul 07 ; 21 (13) . doi:10.3390/ijms21134807
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication. von Brunn A, et. al. (2015); Curr Opin Virol; 2015 Oct; 1456-61. doi:10.1016/j.coviro.2015.08.004
- MERS-CoV infectionsMESH:C000657245 CoV|SARS-CoV, HCoV-NL63|HCoV-NL63, HCoV-HKU1, SARS-CoV and MERS-CoV|coronaviruses SARS-CoV, HCoV-NL63|SARS-CoV and MERS-CoV viruses|SARS-CoV|CoV infectionMESH:C537931 pan-CoVMESH:D001102 viral infectionMESH:D002371 Feline CoV (FCoV) serotypes IMESH:D003324 coronary artery diseaseMESH:D003333 SARS-CoV, HCoV-229E|CoV-229E|HCoV-229E-LUC virus-infectedMESH:D006526 HCV infection|hepatitis C virus infectionMESH:D006528 hepatocellular carcinomaMESH:D007239 FCoV infection|infections|infectionMESH:D011014 pneumoniaMESH:D011488 CoV proteinsMESH:D012131 respiratory syndromeMESH:D012141 respiratory tract infections|infection of respiratory and gastrointestinalMESH:D014842 von Hahn|vonMESH:D015658 virus infectionMESH:D016766 Feline Infectious Peritonitis|CoV Feline Infectious Peritonitis VirusMESH:D018352 middle east respiratory syndrome coronavirus infection|middle East respiratory syndrome|coronavirus HKU1|coronavirus|SARS-coronavirus-host|coronavirus infection|Ausbruch von MERS-Coronavirus|Respiratory Syndrome Coronavirus|SARS coronavirus tightlyMESH:D030342 genetic deficiency|Genetic deficiencyMESH:D045169 Coronaviruses post-SARS
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Will a little change do you good? A putative role of polymorphisms in COVID-19. Paim AAO, et. al. (2021); Immunol Lett; 2021 Apr 23 . doi:10.1016/j.imlet.2021.04.005
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Development and application of sensitive, specific and rapid CRISPR-Cas13-based diagnosis. Gao D, et. al. (2021); J Med Virol; 2021 Feb 18 . doi:10.1002/jmv.26889
Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations. Paniri A, et. al. (2020); Eur J Pharmacol; 2020 Nov 05 ; 886 173454. doi:10.1016/j.ejphar.2020.173454
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Zeberg H, et. al. (2021); Proc Natl Acad Sci U S A; 2021 Mar 02 ; 118 (9) . doi:10.1073/pnas.2026309118
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Novelli G, et. al. (2021); Hum Genomics; 2021 May 10 ; 15 (1) 27. doi:10.1186/s40246-021-00326-3
Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Ghafouri-Fard S, et. al. (2020); Biomed. Pharmacother.; 2020 Aug ; 128 110296. doi:10.1016/j.biopha.2020.110296
Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review). Turrubiates-Hernández FJ, et. al. (2021); Int J Mol Med; 2021 04 ; 47 (4) . doi:10.3892/ijmm.2021.4865
The effect of angiotensin-converting enzyme levels on Covid-19 susceptibility and severity: a Mendelian randomization study. Butler-Laporte G, et. al. (2020); Int J Epidemiol; 2020 Dec 08 . doi:10.1093/ije/dyaa229
Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification. Grolmusz VK, et. al. (2021); Front Immunol; 2021 ; 12 653489. doi:10.3389/fimmu.2021.653489
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals. Zeberg H, et. al. (2021); Proc Natl Acad Sci U S A; 2021 Mar 02 ; 118 (9) . doi:10.1073/pnas.2026309118
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19. Tan DX, et. al. (2020); Molecules; 2020 Sep 25 ; 25 (19) . doi:10.3390/molecules25194410
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19. Duployez N, et. al. (2020); Cancers (Basel); 2020 Jul 21 ; 12 (7) . doi:10.3390/cancers12071992
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Egli A, et. al. (2014); Emerg Microbes Infect; 2014 Jul; 3(7) 51. doi:10.1038/emi.2014.51
MESH:C000657245 SARS-CoVMESH:C536528 van der WaalsMESH:C564133 atopyMESH:D001102 Viral infections|viral infection|viral tropism|Viral infection|viral infectionsMESH:D001249 asthmaMESH:D001327 autoimmune disease|autoimmune diseasesMESH:D001424 bacterial infectionsMESH:D003141 Infectious diseases|infectious diseasesMESH:D003586 cytomegalovirus infectionMESH:D004342 allergic airway diseaseMESH:D005767 gastrointestinalMESH:D006509 hepatitis BMESH:D006526 hepatitis C viral|hepatitis C|hepatitis C virus infections|HCV-infected|chronic HCV infection|Sendai virusand hepatitis C virus|hepatitis C virus-infected|impaired clearance of hepatitis C|HCV infection|hepatitis C virus 1B infection|HIV/HCV co-infected|hepatitis C virus infectionMESH:D006528 hepatomaMESH:D007239 CMV-infected|infectionMESH:D007249 inflammationMESH:D007251 influenza A virus infectionMESH:D007674 embryonic kidneyMESH:D008171 infection of lung|lung diseasesMESH:D008180 systemic lupus erythematosusMESH:D009103 multiple sclerosisMESH:D011565 psoriasisMESH:D014766 CMV viremiaMESH:D015179 CMV infection increases colonicMESH:D015458 T-cell leukemia virus type-1 mono-infectionMESH:D015658 HIV/HCV-coinfected|Hantaan virus infection|HIV|Virus infection|HIV-1 coinfected|immunodeficiency virus type 1 infectionMESH:D018352 respiratory syndrome coronavirusMESH:D019698 chronic hepatitis C virus infection|chronic hepatitis C|chronic hepatitis C viral infection|chronic hepatitis C virus type 1 infection|acute hepatitis CMESH:D020336 spastic paraparesisMESH:D056486 posttransplant hepatitis c infection|liver damage|hepatitisMESH:D059787 acute virus infectionMESH:D060085 HCV-coinfected
Potential immunomodulatory effects of vitamin D in the prevention of severe coronavirus disease 2019: An ally for Latin America (Review). Turrubiates-Hernández FJ, et. al. (2021); Int J Mol Med; 2021 04 ; 47 (4) . doi:10.3892/ijmm.2021.4865
Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19. Di Maria E, et. al. (2020); Pharmacol Res; 2020 Dec 24 105402. doi:10.1016/j.phrs.2020.105402
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Egli A, et. al. (2014); Emerg Microbes Infect; 2014 Jul; 3(7) 51. doi:10.1038/emi.2014.51
MESH:C000657245 SARS-CoVMESH:C536528 van der WaalsMESH:C564133 atopyMESH:D001102 Viral infections|viral infection|viral tropism|Viral infection|viral infectionsMESH:D001249 asthmaMESH:D001327 autoimmune disease|autoimmune diseasesMESH:D001424 bacterial infectionsMESH:D003141 Infectious diseases|infectious diseasesMESH:D003586 cytomegalovirus infectionMESH:D004342 allergic airway diseaseMESH:D005767 gastrointestinalMESH:D006509 hepatitis BMESH:D006526 hepatitis C viral|hepatitis C|hepatitis C virus infections|HCV-infected|chronic HCV infection|Sendai virusand hepatitis C virus|hepatitis C virus-infected|impaired clearance of hepatitis C|HCV infection|hepatitis C virus 1B infection|HIV/HCV co-infected|hepatitis C virus infectionMESH:D006528 hepatomaMESH:D007239 CMV-infected|infectionMESH:D007249 inflammationMESH:D007251 influenza A virus infectionMESH:D007674 embryonic kidneyMESH:D008171 infection of lung|lung diseasesMESH:D008180 systemic lupus erythematosusMESH:D009103 multiple sclerosisMESH:D011565 psoriasisMESH:D014766 CMV viremiaMESH:D015179 CMV infection increases colonicMESH:D015458 T-cell leukemia virus type-1 mono-infectionMESH:D015658 HIV/HCV-coinfected|Hantaan virus infection|HIV|Virus infection|HIV-1 coinfected|immunodeficiency virus type 1 infectionMESH:D018352 respiratory syndrome coronavirusMESH:D019698 chronic hepatitis C virus infection|chronic hepatitis C|chronic hepatitis C viral infection|chronic hepatitis C virus type 1 infection|acute hepatitis CMESH:D020336 spastic paraparesisMESH:D056486 posttransplant hepatitis c infection|liver damage|hepatitisMESH:D059787 acute virus infectionMESH:D060085 HCV-coinfected
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Egli A, et. al. (2014); Emerg Microbes Infect; 2014 Jul; 3(7) 51. doi:10.1038/emi.2014.51
MESH:C000657245 SARS-CoVMESH:C536528 van der WaalsMESH:C564133 atopyMESH:D001102 Viral infections|viral infection|viral tropism|Viral infection|viral infectionsMESH:D001249 asthmaMESH:D001327 autoimmune disease|autoimmune diseasesMESH:D001424 bacterial infectionsMESH:D003141 Infectious diseases|infectious diseasesMESH:D003586 cytomegalovirus infectionMESH:D004342 allergic airway diseaseMESH:D005767 gastrointestinalMESH:D006509 hepatitis BMESH:D006526 hepatitis C viral|hepatitis C|hepatitis C virus infections|HCV-infected|chronic HCV infection|Sendai virusand hepatitis C virus|hepatitis C virus-infected|impaired clearance of hepatitis C|HCV infection|hepatitis C virus 1B infection|HIV/HCV co-infected|hepatitis C virus infectionMESH:D006528 hepatomaMESH:D007239 CMV-infected|infectionMESH:D007249 inflammationMESH:D007251 influenza A virus infectionMESH:D007674 embryonic kidneyMESH:D008171 infection of lung|lung diseasesMESH:D008180 systemic lupus erythematosusMESH:D009103 multiple sclerosisMESH:D011565 psoriasisMESH:D014766 CMV viremiaMESH:D015179 CMV infection increases colonicMESH:D015458 T-cell leukemia virus type-1 mono-infectionMESH:D015658 HIV/HCV-coinfected|Hantaan virus infection|HIV|Virus infection|HIV-1 coinfected|immunodeficiency virus type 1 infectionMESH:D018352 respiratory syndrome coronavirusMESH:D019698 chronic hepatitis C virus infection|chronic hepatitis C|chronic hepatitis C viral infection|chronic hepatitis C virus type 1 infection|acute hepatitis CMESH:D020336 spastic paraparesisMESH:D056486 posttransplant hepatitis c infection|liver damage|hepatitisMESH:D059787 acute virus infectionMESH:D060085 HCV-coinfected
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Egli A, et. al. (2014); Emerg Microbes Infect; 2014 Jul; 3(7) 51. doi:10.1038/emi.2014.51
MESH:C000657245 SARS-CoVMESH:C536528 van der WaalsMESH:C564133 atopyMESH:D001102 Viral infections|viral infection|viral tropism|Viral infection|viral infectionsMESH:D001249 asthmaMESH:D001327 autoimmune disease|autoimmune diseasesMESH:D001424 bacterial infectionsMESH:D003141 Infectious diseases|infectious diseasesMESH:D003586 cytomegalovirus infectionMESH:D004342 allergic airway diseaseMESH:D005767 gastrointestinalMESH:D006509 hepatitis BMESH:D006526 hepatitis C viral|hepatitis C|hepatitis C virus infections|HCV-infected|chronic HCV infection|Sendai virusand hepatitis C virus|hepatitis C virus-infected|impaired clearance of hepatitis C|HCV infection|hepatitis C virus 1B infection|HIV/HCV co-infected|hepatitis C virus infectionMESH:D006528 hepatomaMESH:D007239 CMV-infected|infectionMESH:D007249 inflammationMESH:D007251 influenza A virus infectionMESH:D007674 embryonic kidneyMESH:D008171 infection of lung|lung diseasesMESH:D008180 systemic lupus erythematosusMESH:D009103 multiple sclerosisMESH:D011565 psoriasisMESH:D014766 CMV viremiaMESH:D015179 CMV infection increases colonicMESH:D015458 T-cell leukemia virus type-1 mono-infectionMESH:D015658 HIV/HCV-coinfected|Hantaan virus infection|HIV|Virus infection|HIV-1 coinfected|immunodeficiency virus type 1 infectionMESH:D018352 respiratory syndrome coronavirusMESH:D019698 chronic hepatitis C virus infection|chronic hepatitis C|chronic hepatitis C viral infection|chronic hepatitis C virus type 1 infection|acute hepatitis CMESH:D020336 spastic paraparesisMESH:D056486 posttransplant hepatitis c infection|liver damage|hepatitisMESH:D059787 acute virus infectionMESH:D060085 HCV-coinfected
The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy. Bruening J, et. al. (2017); J Immunol Res; 2017; 20177232361. doi:10.1155/2017/7232361
MESH:C000657245 SARS-CoVMESH:D000309 insufficientMESH:D001102 Viral infections|viral infection|Viral infection|viral infectionsMESH:D001424 bacterial infectionsMESH:D001651 extrahepatic diseasesMESH:D002780 intrahepatic infectionMESH:D004342 allergyMESH:D005355 fibrosis|cirrhosisMESH:D006509 hepatitis BMESH:D006525 viral hepatitisMESH:D006526 infected chimpanzees HCV infection|Hepatitis C Virus Infection|Hepatitis C Virus|impaired clearance of hepatitis C|HCV infection|hepatitis C|hepatitis C virus infections|chronic HCV infection|Hepatitis C|hepatitis C disease|contracting hepatitis C|hepatitis C virus-infected|Modeling hepatitis C virus infection|acute HCV infection|acute hepatitis C virus infection|hepatitis C virus infectionMESH:D006528 hepatocellular carcinoma|hepatoma|HepatomaMESH:D007239 infections|infectionMESH:D007249 inflammation|liver inflammationMESH:D007251 influenza A virus infectionMESH:D007635 myeloid dendriticMESH:D008545 melanomaMESH:D009404 NSMESH:D014766 viremiaMESH:D015658 HIV/HCV-coinfected|hepatotropic virus infection|Hantaan virus infection|virus infections|Virus infection|virus infection|immunodeficiency virus type 1 infectionMESH:D016751 hepatitis EMESH:D017093 liver failure|liver infectionMESH:D019698 chronic hepatitis C infection|chronic hepatitis C|chronic hepatitis C viral infection|CHCMESH:D056486 hepatic infections|HCV-induced liver damage|hepatitisMESH:D059787 acute infectionMESH:D065626 nonalcoholic fatty liver disease
The Role of Antioxidants Supplementation in Clinical Practice: Focus on Cardiovascular Risk Factors. Cammisotto V, et. al. (2021); Antioxidants (Basel); 2021 Jan 20 ; 10 (2) . doi:10.3390/antiox10020146
"Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Malik A, et. al. (2020); Front Oncol; 2020 ; 10 627701. doi:10.3389/fonc.2020.627701
MESH:C000657245 SARS-CoV-2 infection|Coronavirus Disease 2019|COVID-19-Related Liver Functional Abnormality|COVID-19MESH:C537005 Complement Component C5|Complement component C5|complement component C5MESH:C537062 necrotic tumors harboredMESH:C557675 tracheaMESH:C562875 CFH Decreased Increases hepatocellular inflammation|CFH-deficient|Complement factor H-deficientMESH:C563602 MBL-deficientMESH:C565169 C3; complement C3-deficient HSCs|Complement Component C3MESH:C566443 Complement proteins C7|Complement Component C4|absence of C7 and CFH abrogated tumor|CFH and complement component C7MESH:D000077216 epithelial ovarian cancerMESH:D000077277 esophageal squamous cell carcinomaMESH:D000079225 hypoxic stressMESH:D000080223 chronic urticariaMESH:D000081207 Primary Immunodeficiency|impaired complementMESH:D000208 acute injuryMESH:D000437 alcohol abuseMESH:D000860 hypoxiaMESH:D001068 loss of appetite|decreased appetiteMESH:D001102 virus infection|viral infectionsMESH:D001168 arthritisMESH:D001172 rheumatoid arthritisMESH:D001201 ascites of hepatocellular carcinoma|ascitesMESH:D001249 asthmaMESH:D001327 autoimmune diseasesMESH:D001424 pyogenic bacterial infectionsMESH:D001523 aggressive disease|aggressivenessMESH:D001656 Biliary atresiaMESH:D001749 carcinoma of the urinary bladder|bladder cancerMESH:D001778 complement-coagulation|CoagulationMESH:D001791 platelet aggregationMESH:D001943 breast tumors|breast tumours|breast cancer|invasive breast carcinoma|breast cancer metastasisMESH:D002289 NSCLC|Non-small cell lung cancer|non-small cell lung cancerMESH:D002294 squamous cell lung cancerMESH:D002303 decreased tumorMESH:D002583 cervical cancersMESH:D002779 cholestatic diseases|bile duct injuryMESH:D003248 constipationMESH:D003324 ischemic myocardiumMESH:D003643 mortality|Mortality|deaths|deathMESH:D003711 demyelinationMESH:D003920 diabetes mellitus|diabetesMESH:D003967 KIT Diarrhea|diarrheaMESH:D004211 intravascular coagulationMESH:D004416 dysplasticMESH:D004417 dyspneaMESH:D004487 swellingMESH:D004715 endometriomasMESH:D005076 PD-1 AbPD-L1 AbCTLA-4 Ab Skin rashMESH:D005221 fatigueMESH:D005234 liver steatosis|steatohepatitisMESH:D005334 feverMESH:D005354 fibrosarcomaMESH:D005355 fibrosis|cirrhosis|CirrhosisMESH:D005402 fistulaMESH:D005921 glomerulonephritisMESH:D005935 tumor burdenDecreased cell apoptosisPoor overallMESH:D006323 arrestMESH:D006327 block tumorMESH:D006331 cardiac diseasesMESH:D006406 hematomaMESH:D006457 paroxysmal nocturnal hemoglobinuriaMESH:D006463 HUSMESH:D006470 bleedingMESH:D006509 HBV infection|hepatitis B virus (HBV) infection|Hepatitis B virus, Hepatitis C virus|hepatitis B-related cirrhosis|hepatitis B cirrhosis|hepatitis B virus related hepatocellular carcinoma|hepatitis B virus|HBV-HCC and HBV-chronic hepatitis B risks|hepatitis B virus X|hepatitis B|hepatitis B virus infection|HBV-HCC and HBV-Chronic hepatitis BMESH:D006526 hepatocellular carcinoma in chronic HCV infection|C4 complement by hepatitis C virus proteins|HCV-infected|chronic HCV infection|HCV disease|hepatocellular carcinoma in HCV-infected alcoholic|HCV infection|HBV/HCV infection|hepatitis C virus (HCV) infection|hepatitis C virus infection|hepatitis C virus-related hepatocellular carcinoma|HCV-infected alcoholicMESH:D006528 hepatocellular carcinoma aggressiveness|liver and gastrointestinal cancers|Advanced Hepatocellular Carcinoma|peritumoral stroma of hepatocellular carcinoma foster immune privilege|hepatocellular carcinoma cell invasiveness|Hepatocellular Carcinoma|Inflammation and Liver Cancer|hepatocellular tumor|hepatocellular carcinomas|hepatocellular carcinoma prolong|HepG-2 hepatoma|Hepatocellular carcinoma|Tackling hepatocellular carcinoma|HCC stemness|HCC tumors|HCC lesions|IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction|complement proteins in hepatocellular carcinoma|hepatocellular carcinoma|liver cancer|HCC progressionIncreases HSC|HCC tumor|hepatoma|Hepatocellular Carcinoma by Producing Complement C3|stemness of liver cancer|Liver CancersMESH:D006973 hypertensionMESH:D007037 hypothyroidismMESH:D007153 deficiency|Complement deficiency|complement CICs|immunodeficiencyMESH:D007239 infections|infection|infectedMESH:D007249 inflammatory disorders|inflammation|fibro-inflammation|Inflammation|hepatocellular inflammation|Decreased Increases hepatocellular inflammation|liver inflammationMESH:D007674 transplantation PainMESH:D007938 leukemic|leukemiaMESH:D008100 hepatic abscessMESH:D008103 liver cirrhosis|HCC and Liver Cirrhosis|liver fibrosis|chronic hepatitis and liver cirrhosis|HBV-liver cirrhosis|hepatic cirrhosisMESH:D008105 Primary Sclerosing Cholangitis, Primary Biliary CirrhosisMESH:D008107 liver disease|liver diseases|hepatic dysfunctionMESH:D008113 liver tumors|liver tumorMESH:D008175 Lung Cancer|lung cancer|Axis Impairs Lung CancerMESH:D008180 systemic lupus erythematosus|SLEMESH:D008223 lymphomaMESH:D008228 non-Hodgkin lymphomaMESH:D008545 MelanomaMESH:D008649 ovarian clear cell carcinomaMESH:D009101 myeloma|multiple myelomaMESH:D009103 multiple sclerosis|Multiple sclerosisMESH:D009203 myocardial infarctionMESH:D009325 nauseaMESH:D009336 necrosis|necrotic|NecrosisMESH:D009361 increase invasiveness|tumor invasivenessMESH:D009362 metastases|hepatocarcinoma intrahepatic metastasis|hepatocellular carcinoma metastasis via NF-kB|metastasis of hepatocellular carcinoma|Complementing Cancer Metastasis|tumor metastases of colon cancer|Metastases of Colon Cancer|liver metastasis|venous metastases|tumor metastasis|Liver MetastasesMESH:D009369 aggressive cancer|Cancer|immunogenic cancer|tumor|cancers|III tumors|tumor-initiating hepatocarcinoma|Malignancies|malignancies|tumors|malignant tumors|Oral Cancer|tumours|malignancy|cancer|tumor angiogenesisPromotes cancer cell metastasisEnhances invasiveness of cancer|hepatocellular neoplasia|cancer tumor|Malignant Diseases|tumourMESH:D009503 neutropenia|febrile neutropeniaMESH:D009765 obesityMESH:D010049 ovarian|colorectal, ovarianMESH:D010051 malignant and benign ovarian tumoursMESH:D010146 painMESH:D010190 pancreatic cancerMESH:D010300 PD-1 ICIs|PD-L1 ICIsMESH:D010534 PeritonitisMESH:D011014 inflammatory lung diseaseMESH:D011471 prostate cancer|hyperplasia in prostate cancerMESH:D011537 pruritisMESH:D012021 absent tumorMESH:D012170 vein occlusionMESH:D012216 rheumatic diseasesMESH:D012421 ruptureMESH:D012598 sclerosisMESH:D012769 hypovolemic shockMESH:D013274 gastric cancerMESH:D013724 deficiencies and immatureMESH:D013927 thrombosisMESH:D014581 urticariaMESH:D015179 colorectal cancer|colorectal|CRC|colon cancer|Colorectal Cancer|colon cancer tumorMESH:D015431 weight loss, joints|weight lossMESH:D015433 membranous glomerulonephritisMESH:D015464 chronic myeloid leukemiaMESH:D016393 B-cell lymphoma|B cell lymphomaMESH:D016543 CNS tumorsMESH:D016553 autoimmune thrombocytopeniaMESH:D016870 neisserialMESH:D016920 bacterial peritonitisMESH:D017093 malignancy of the liver|Liver failure|decreased liver functions|liver cirrhosisPoor|liver lesions|liver failure|liver injury|hepatic failure|Liver Injury|liver stromaMESH:D017564 radiation pneumonitisMESH:D018281 intrahepatic cholangiocarcinomaMESH:D018455 GPI-anchored proteinsMESH:D018980 WilliamsMESH:D019337 hematologic malignanciesMESH:D019694 chronic hepatitis B|chronic hepatitis B infectionMESH:D019698 chronic hepatitis CMESH:D020295 stemness of tumorMESH:D024821 metabolic syndromeMESH:D030342 genetic obesity promote liver inflammationMESH:D041781 obstructive jaundiceMESH:D050197 atherosclerosisMESH:D051270 alarming riseMESH:D051437 renal failureMESH:D054066 NK cell dysfunctionMESH:D054179 hereditary angioedemaMESH:D054198 acute lymphoblastic leukemiaMESH:D054391 NK-TMESH:D056486 hepatic injury|liver toxicity|hepatic neoplasia|liver damage|hepatic tumors|Hepatitis|hepatotoxicity|hepatitisMESH:D057772 vascular injuryMESH:D058625 chronic liver disease|end-stage liver disease|Chronic Liver DiseaseMESH:D059352 musculoskeletal painMESH:D060085 secondary infectionsMESH:D060831 hand-foot syndromeMESH:D063646 hepatocarcinogenesis|liver carcinogenesis|proliferationIncreases tumorigenesis and tumor|Carcinogenesis|Complement C5a Fosters Squamous Carcinogenesis|carcinogenesisMESH:D064420 cytotoxicity|cytotoxicity of tumour|block NK cell cytotoxicities|metastasis Increases cytotoxicity|cancer cell cytotoxicity|Decreases complement cytotoxicity
Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification. Grolmusz VK, et. al. (2021); Front Immunol; 2021 ; 12 653489. doi:10.3389/fimmu.2021.653489
"Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Malik A, et. al. (2020); Front Oncol; 2020 ; 10 627701. doi:10.3389/fonc.2020.627701
MESH:C000657245 SARS-CoV-2 infection|Coronavirus Disease 2019|COVID-19-Related Liver Functional Abnormality|COVID-19MESH:C537005 Complement Component C5|Complement component C5|complement component C5MESH:C537062 necrotic tumors harboredMESH:C557675 tracheaMESH:C562875 CFH Decreased Increases hepatocellular inflammation|CFH-deficient|Complement factor H-deficientMESH:C563602 MBL-deficientMESH:C565169 C3; complement C3-deficient HSCs|Complement Component C3MESH:C566443 Complement proteins C7|Complement Component C4|absence of C7 and CFH abrogated tumor|CFH and complement component C7MESH:D000077216 epithelial ovarian cancerMESH:D000077277 esophageal squamous cell carcinomaMESH:D000079225 hypoxic stressMESH:D000080223 chronic urticariaMESH:D000081207 Primary Immunodeficiency|impaired complementMESH:D000208 acute injuryMESH:D000437 alcohol abuseMESH:D000860 hypoxiaMESH:D001068 loss of appetite|decreased appetiteMESH:D001102 virus infection|viral infectionsMESH:D001168 arthritisMESH:D001172 rheumatoid arthritisMESH:D001201 ascites of hepatocellular carcinoma|ascitesMESH:D001249 asthmaMESH:D001327 autoimmune diseasesMESH:D001424 pyogenic bacterial infectionsMESH:D001523 aggressive disease|aggressivenessMESH:D001656 Biliary atresiaMESH:D001749 carcinoma of the urinary bladder|bladder cancerMESH:D001778 complement-coagulation|CoagulationMESH:D001791 platelet aggregationMESH:D001943 breast tumors|breast tumours|breast cancer|invasive breast carcinoma|breast cancer metastasisMESH:D002289 NSCLC|Non-small cell lung cancer|non-small cell lung cancerMESH:D002294 squamous cell lung cancerMESH:D002303 decreased tumorMESH:D002583 cervical cancersMESH:D002779 cholestatic diseases|bile duct injuryMESH:D003248 constipationMESH:D003324 ischemic myocardiumMESH:D003643 mortality|Mortality|deaths|deathMESH:D003711 demyelinationMESH:D003920 diabetes mellitus|diabetesMESH:D003967 KIT Diarrhea|diarrheaMESH:D004211 intravascular coagulationMESH:D004416 dysplasticMESH:D004417 dyspneaMESH:D004487 swellingMESH:D004715 endometriomasMESH:D005076 PD-1 AbPD-L1 AbCTLA-4 Ab Skin rashMESH:D005221 fatigueMESH:D005234 liver steatosis|steatohepatitisMESH:D005334 feverMESH:D005354 fibrosarcomaMESH:D005355 fibrosis|cirrhosis|CirrhosisMESH:D005402 fistulaMESH:D005921 glomerulonephritisMESH:D005935 tumor burdenDecreased cell apoptosisPoor overallMESH:D006323 arrestMESH:D006327 block tumorMESH:D006331 cardiac diseasesMESH:D006406 hematomaMESH:D006457 paroxysmal nocturnal hemoglobinuriaMESH:D006463 HUSMESH:D006470 bleedingMESH:D006509 HBV infection|hepatitis B virus (HBV) infection|Hepatitis B virus, Hepatitis C virus|hepatitis B-related cirrhosis|hepatitis B cirrhosis|hepatitis B virus related hepatocellular carcinoma|hepatitis B virus|HBV-HCC and HBV-chronic hepatitis B risks|hepatitis B virus X|hepatitis B|hepatitis B virus infection|HBV-HCC and HBV-Chronic hepatitis BMESH:D006526 hepatocellular carcinoma in chronic HCV infection|C4 complement by hepatitis C virus proteins|HCV-infected|chronic HCV infection|HCV disease|hepatocellular carcinoma in HCV-infected alcoholic|HCV infection|HBV/HCV infection|hepatitis C virus (HCV) infection|hepatitis C virus infection|hepatitis C virus-related hepatocellular carcinoma|HCV-infected alcoholicMESH:D006528 hepatocellular carcinoma aggressiveness|liver and gastrointestinal cancers|Advanced Hepatocellular Carcinoma|peritumoral stroma of hepatocellular carcinoma foster immune privilege|hepatocellular carcinoma cell invasiveness|Hepatocellular Carcinoma|Inflammation and Liver Cancer|hepatocellular tumor|hepatocellular carcinomas|hepatocellular carcinoma prolong|HepG-2 hepatoma|Hepatocellular carcinoma|Tackling hepatocellular carcinoma|HCC stemness|HCC tumors|HCC lesions|IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction|complement proteins in hepatocellular carcinoma|hepatocellular carcinoma|liver cancer|HCC progressionIncreases HSC|HCC tumor|hepatoma|Hepatocellular Carcinoma by Producing Complement C3|stemness of liver cancer|Liver CancersMESH:D006973 hypertensionMESH:D007037 hypothyroidismMESH:D007153 deficiency|Complement deficiency|complement CICs|immunodeficiencyMESH:D007239 infections|infection|infectedMESH:D007249 inflammatory disorders|inflammation|fibro-inflammation|Inflammation|hepatocellular inflammation|Decreased Increases hepatocellular inflammation|liver inflammationMESH:D007674 transplantation PainMESH:D007938 leukemic|leukemiaMESH:D008100 hepatic abscessMESH:D008103 liver cirrhosis|HCC and Liver Cirrhosis|liver fibrosis|chronic hepatitis and liver cirrhosis|HBV-liver cirrhosis|hepatic cirrhosisMESH:D008105 Primary Sclerosing Cholangitis, Primary Biliary CirrhosisMESH:D008107 liver disease|liver diseases|hepatic dysfunctionMESH:D008113 liver tumors|liver tumorMESH:D008175 Lung Cancer|lung cancer|Axis Impairs Lung CancerMESH:D008180 systemic lupus erythematosus|SLEMESH:D008223 lymphomaMESH:D008228 non-Hodgkin lymphomaMESH:D008545 MelanomaMESH:D008649 ovarian clear cell carcinomaMESH:D009101 myeloma|multiple myelomaMESH:D009103 multiple sclerosis|Multiple sclerosisMESH:D009203 myocardial infarctionMESH:D009325 nauseaMESH:D009336 necrosis|necrotic|NecrosisMESH:D009361 increase invasiveness|tumor invasivenessMESH:D009362 metastases|hepatocarcinoma intrahepatic metastasis|hepatocellular carcinoma metastasis via NF-kB|metastasis of hepatocellular carcinoma|Complementing Cancer Metastasis|tumor metastases of colon cancer|Metastases of Colon Cancer|liver metastasis|venous metastases|tumor metastasis|Liver MetastasesMESH:D009369 aggressive cancer|Cancer|immunogenic cancer|tumor|cancers|III tumors|tumor-initiating hepatocarcinoma|Malignancies|malignancies|tumors|malignant tumors|Oral Cancer|tumours|malignancy|cancer|tumor angiogenesisPromotes cancer cell metastasisEnhances invasiveness of cancer|hepatocellular neoplasia|cancer tumor|Malignant Diseases|tumourMESH:D009503 neutropenia|febrile neutropeniaMESH:D009765 obesityMESH:D010049 ovarian|colorectal, ovarianMESH:D010051 malignant and benign ovarian tumoursMESH:D010146 painMESH:D010190 pancreatic cancerMESH:D010300 PD-1 ICIs|PD-L1 ICIsMESH:D010534 PeritonitisMESH:D011014 inflammatory lung diseaseMESH:D011471 prostate cancer|hyperplasia in prostate cancerMESH:D011537 pruritisMESH:D012021 absent tumorMESH:D012170 vein occlusionMESH:D012216 rheumatic diseasesMESH:D012421 ruptureMESH:D012598 sclerosisMESH:D012769 hypovolemic shockMESH:D013274 gastric cancerMESH:D013724 deficiencies and immatureMESH:D013927 thrombosisMESH:D014581 urticariaMESH:D015179 colorectal cancer|colorectal|CRC|colon cancer|Colorectal Cancer|colon cancer tumorMESH:D015431 weight loss, joints|weight lossMESH:D015433 membranous glomerulonephritisMESH:D015464 chronic myeloid leukemiaMESH:D016393 B-cell lymphoma|B cell lymphomaMESH:D016543 CNS tumorsMESH:D016553 autoimmune thrombocytopeniaMESH:D016870 neisserialMESH:D016920 bacterial peritonitisMESH:D017093 malignancy of the liver|Liver failure|decreased liver functions|liver cirrhosisPoor|liver lesions|liver failure|liver injury|hepatic failure|Liver Injury|liver stromaMESH:D017564 radiation pneumonitisMESH:D018281 intrahepatic cholangiocarcinomaMESH:D018455 GPI-anchored proteinsMESH:D018980 WilliamsMESH:D019337 hematologic malignanciesMESH:D019694 chronic hepatitis B|chronic hepatitis B infectionMESH:D019698 chronic hepatitis CMESH:D020295 stemness of tumorMESH:D024821 metabolic syndromeMESH:D030342 genetic obesity promote liver inflammationMESH:D041781 obstructive jaundiceMESH:D050197 atherosclerosisMESH:D051270 alarming riseMESH:D051437 renal failureMESH:D054066 NK cell dysfunctionMESH:D054179 hereditary angioedemaMESH:D054198 acute lymphoblastic leukemiaMESH:D054391 NK-TMESH:D056486 hepatic injury|liver toxicity|hepatic neoplasia|liver damage|hepatic tumors|Hepatitis|hepatotoxicity|hepatitisMESH:D057772 vascular injuryMESH:D058625 chronic liver disease|end-stage liver disease|Chronic Liver DiseaseMESH:D059352 musculoskeletal painMESH:D060085 secondary infectionsMESH:D060831 hand-foot syndromeMESH:D063646 hepatocarcinogenesis|liver carcinogenesis|proliferationIncreases tumorigenesis and tumor|Carcinogenesis|Complement C5a Fosters Squamous Carcinogenesis|carcinogenesisMESH:D064420 cytotoxicity|cytotoxicity of tumour|block NK cell cytotoxicities|metastasis Increases cytotoxicity|cancer cell cytotoxicity|Decreases complement cytotoxicity
The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System. Świerzko AS, et. al. (2020); Front Immunol; 2020 ; 11 585243. doi:10.3389/fimmu.2020.585243
MBL2 polymorphisms in a variety of infectious diseases by the future studies.">The ambiguous role of mannose-binding lectin (MBL) in human immunity. Kalia N, et. al. (2021); Open Med (Wars); 2021 ; 16 (1) 299-310. doi:10.1515/med-2021-0239
Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies. Dos Santos ACM, et. al. (2021); Infect Genet Evol; 2021 Apr 29 104846. doi:10.1016/j.meegid.2021.104846
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Zubiaur P, et. al. (2020); Clin Transl Sci; 2020 Sep 16 . doi:10.1111/cts.12866
Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19. Liu D, et. al. (2020); J Infect; 2020 Nov 28 . doi:10.1016/j.jinf.2020.11.031
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants. Shoily SS, et. al. (2021); Infect Genet Evol; 2021 Apr 29 104888. doi:10.1016/j.meegid.2021.104888
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences. Barash A, et. al. (2020); Front Med (Lausanne); 2020 ; 7 582793. doi:10.3389/fmed.2020.582793
MESH:C000657245 coronavirus disease 2019|SARS-CoV-2 infection|Covid-19|covid|COVID-19MESH:D001102 viral infection|Viral infectionMESH:D002318 cardiovascular disease|Cardiovascular diseaseMESH:D003316 corneal epitheliumMESH:D003371 dry coughMESH:D003643 mortality|deathMESH:D003875 eruptionsMESH:D003920 diabetesMESH:D003924 type 2 diabetes mellitusMESH:D003967 diarrheaMESH:D004417 breathlessnessMESH:D005067 High Low High Low HighMESH:D005221 fatigueMESH:D005334 feverMESH:D005706 Liver and gall bladderMESH:D006261 headacheMESH:D006331 heart diseasesMESH:D006973 hypertensionMESH:D007153 immunodeficiencyMESH:D007239 infection|infectedMESH:D007249 inflammationMESH:D007674 High KidneyMESH:D009102 multi-organ failureMESH:D009325 nauseaMESH:D009369 cancerous|cancer diseaseMESH:D009765 obesityMESH:D009800 High Low High Low N|Skin Low High NMESH:D010661 HPAMESH:D011014 pneumoniaMESH:D013651 loss of tasteMESH:D014839 vomitingMESH:D018352 coronavirus infectionMESH:D051437 renal failureMESH:D052456 High High HighMESH:D056128 abdominal obesityMESH:D063806 myalgia
Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches. Mozzi A, et. al. (2017); Infect. Genet. Evol.; 2017 Sep 22. doi:10.1016/j.meegid.2017.09.028
Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19. Liu D, et. al. (2020); J Infect; 2020 Nov 28 . doi:10.1016/j.jinf.2020.11.031
How Genetics Might Explain the Unusual Link Between Malaria and COVID-19. Rusmini M, et. al. (2021); Front Med (Lausanne); 2021 ; 8 650231. doi:10.3389/fmed.2021.650231
Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis. Di Maria E, et. al. (2020); Hum Genomics; 2020 09 11 ; 14 (1) 30. doi:10.1186/s40246-020-00280-6
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
The landscape of host genetic factors involved in infection to common viruses and SARS-CoV-2. Kachuri L, et. al. (2020); medRxiv; 2020 May 30 . doi:10.1101/2020.05.01.20088054
Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients. Fröhlich E, et. al. (2021); Front Endocrinol (Lausanne); 2021 ; 12 587518. doi:10.3389/fendo.2021.587518
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Ghafouri-Fard S, et. al. (2020); Biomed. Pharmacother.; 2020 Aug ; 128 110296. doi:10.1016/j.biopha.2020.110296
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Bosso M, et. al. (2020); Mol Ther Methods Clin Dev; 2020 Sep 11 ; 18 321-327. doi:10.1016/j.omtm.2020.06.017
ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Al-Mulla F, et. al. (2021); Heliyon; 2021 Feb ; 7 (2) 06133. doi:10.1016/j.heliyon.2021.e06133
Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic. Zhang S, et. al. (2021); Drug Des Devel Ther; 2021 ; 15 983-995. doi:10.2147/DDDT.S298691
MESH:C000657245 covid-19|COVID-19 pneumonia|coronavirus disease 2019|SARS-CoV infection|Coronavirus Disease 2019-related dyspnea|SARS-Cov infection|COVID 19|COVID-19|COVID|2019 Novel Coronavirus-Infected Pneumonia|SARS-CoV-2 pneumonia|2019-nCoV lung injury|Coronavirus Disease 2019 Pneumonia|COVID-19 Pneumonia|Covid-19|coronavirus disease-2019|SARS-CoV-2 Infection|CoV-2 infections|SARS coronavirus SMESH:D000070603 idiopathic osteonecrosis of femoral head|femoral head osteonecrosis|II femoral head osteonecrosis|femoral head ischaemia|osteonecrosis of the femoral head|osteonecrosis of femoral headMESH:D000080902 alveolar injuryMESH:D000310 adrenal suppressionMESH:D000740 anemiaMESH:D000741 aplastic anaemiaMESH:D000860 hypoxemiaMESH:D001102 viral infectionsMESH:D001249 asthmaMESH:D001327 autoimmune diseasesMESH:D001424 bacterial infectionMESH:D001523 mental disordersMESH:D001851 bone metabolism abnormalitiesMESH:D001855 bone marrow oedemaMESH:D001859 osteonecrotic boneMESH:D002318 cardiovascular diseaseMESH:D002637 chest tightness and dyspnoea|chest tightnessMESH:D003371 coughMESH:D003480 Cushing's syndromeMESH:D003643 Mortality|mortality|Death|died|deathMESH:D003920 diabeticMESH:D004211 intravascular coagulationMESH:D004417 dyspnea|dyspnoeaMESH:D004696 EndocarditisMESH:D004697 bacterial endocarditisMESH:D005271 femoral head avascular necrosis|Femoral Head Necrosis|Avascular Necrosis of the Femoral|avascular necrosis of the femoral head|necrosis of the femoral head|femoral head necrosis|osteonecrosis of the femoral|Femoral head necrosisMESH:D005334 fever|FeverMESH:D006453 hemoglobinopathiesMESH:D006943 hyperglycemia|HyperglycemiaMESH:D006949 hyperlipidemiaMESH:D007239 Infections|infections|infection|infectedMESH:D007249 inFlammation|inflammation|Neutrophilic InflammationMESH:D007511 ischaemic necrosisMESH:D008180 osteonecrosis in systemic lupus erythematosus|systemic lupus erythematosusMESH:D009081 FHN ARCO IMESH:D009181 fungal infectionMESH:D009336 necrosis|tumor necrosis|necroticMESH:D010020 Avascular necrosis|Hip Osteonecrosis|non-traumatic osteonecrosis|avascular necrosis|Avascular osteonecrosis|osteonecrosis|Osteonecrosis of hip|traumatic osteonecrosis|Hip osteonecrosis|extremity osteonecrosis|Non traumatic osteonecrosis|Osteonecrosis|nontraumatic osteonecrosisMESH:D010024 OsteoporosisMESH:D010146 painMESH:D011014 pneumoniaMESH:D012120 acute respiratory syndromeMESH:D012128 Acute Respiratory Distress Syndrome|ARDS|acute respiratory distress syndromeMESH:D012131 respiratory functionMESH:D012734 osteoblastic differentiationMESH:D012769 High-energy shockMESH:D012772 septic shockMESH:D013923 thromboembolismMESH:D014657 vasculitisMESH:D015658 human immunodeficiency virus infectionMESH:D016638 Critically ill|critically ill|Critically IllMESH:D018352 coronavirus infection|human coronavirus infections|coronAvirus PneumoniaMESH:D018771 joint painMESH:D020246 vEnous thRombosisMESH:D020766 emboli damageMESH:D029424 chronic obstructive pulmonary diseaseMESH:D045169 SARS|severe acute respiratory syndrome coronavirus-infected|SARS osteonecrosis|severe acute respiratory syndromeMESH:D050171 dyslipidemiaMESH:D055370 lung injuryMESH:D055371 acute lung injuryMESH:D058866 osteoporotic
Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak. Kozlovskaya L, et. al. (2020); Int J Infect Dis; 2020 Oct ; 99 40-46. doi:10.1016/j.ijid.2020.07.024
Structure of a pentameric virion-associated fiber with a potential role in Orsay virus entry to host cells. Fan Y, et. al. (2017); PLoS Pathog.; 2017 Feb; 13(2) 1006231. doi:10.1371/journal.ppat.1006231
Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants. Shoily SS, et. al. (2021); Infect Genet Evol; 2021 Apr 29 104888. doi:10.1016/j.meegid.2021.104888
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories. Hynds RE, et. al. (2021); Open Biol; 2021 Jan ; 11 (1) 200247. doi:10.1098/rsob.200247
A Disintegrin and Metalloproteinase-Control Elements in Infectious Diseases. Aljohmani A, et. al. (2020); Front Cardiovasc Med; 2020 ; 7 608281. doi:10.3389/fcvm.2020.608281
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations. Paniri A, et. al. (2020); J. Biomol. Struct. Dyn.; 2020 Jun 01 1-18. doi:10.1080/07391102.2020.1767690
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Egli A, et. al. (2014); Emerg Microbes Infect; 2014 Jul; 3(7) 51. doi:10.1038/emi.2014.51
MESH:C000657245 SARS-CoVMESH:C536528 van der WaalsMESH:C564133 atopyMESH:D001102 Viral infections|viral infection|viral tropism|Viral infection|viral infectionsMESH:D001249 asthmaMESH:D001327 autoimmune disease|autoimmune diseasesMESH:D001424 bacterial infectionsMESH:D003141 Infectious diseases|infectious diseasesMESH:D003586 cytomegalovirus infectionMESH:D004342 allergic airway diseaseMESH:D005767 gastrointestinalMESH:D006509 hepatitis BMESH:D006526 hepatitis C viral|hepatitis C|hepatitis C virus infections|HCV-infected|chronic HCV infection|Sendai virusand hepatitis C virus|hepatitis C virus-infected|impaired clearance of hepatitis C|HCV infection|hepatitis C virus 1B infection|HIV/HCV co-infected|hepatitis C virus infectionMESH:D006528 hepatomaMESH:D007239 CMV-infected|infectionMESH:D007249 inflammationMESH:D007251 influenza A virus infectionMESH:D007674 embryonic kidneyMESH:D008171 infection of lung|lung diseasesMESH:D008180 systemic lupus erythematosusMESH:D009103 multiple sclerosisMESH:D011565 psoriasisMESH:D014766 CMV viremiaMESH:D015179 CMV infection increases colonicMESH:D015458 T-cell leukemia virus type-1 mono-infectionMESH:D015658 HIV/HCV-coinfected|Hantaan virus infection|HIV|Virus infection|HIV-1 coinfected|immunodeficiency virus type 1 infectionMESH:D018352 respiratory syndrome coronavirusMESH:D019698 chronic hepatitis C virus infection|chronic hepatitis C|chronic hepatitis C viral infection|chronic hepatitis C virus type 1 infection|acute hepatitis CMESH:D020336 spastic paraparesisMESH:D056486 posttransplant hepatitis c infection|liver damage|hepatitisMESH:D059787 acute virus infectionMESH:D060085 HCV-coinfected
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Egli A, et. al. (2014); Emerg Microbes Infect; 2014 Jul; 3(7) 51. doi:10.1038/emi.2014.51
MESH:C000657245 SARS-CoVMESH:C536528 van der WaalsMESH:C564133 atopyMESH:D001102 Viral infections|viral infection|viral tropism|Viral infection|viral infectionsMESH:D001249 asthmaMESH:D001327 autoimmune disease|autoimmune diseasesMESH:D001424 bacterial infectionsMESH:D003141 Infectious diseases|infectious diseasesMESH:D003586 cytomegalovirus infectionMESH:D004342 allergic airway diseaseMESH:D005767 gastrointestinalMESH:D006509 hepatitis BMESH:D006526 hepatitis C viral|hepatitis C|hepatitis C virus infections|HCV-infected|chronic HCV infection|Sendai virusand hepatitis C virus|hepatitis C virus-infected|impaired clearance of hepatitis C|HCV infection|hepatitis C virus 1B infection|HIV/HCV co-infected|hepatitis C virus infectionMESH:D006528 hepatomaMESH:D007239 CMV-infected|infectionMESH:D007249 inflammationMESH:D007251 influenza A virus infectionMESH:D007674 embryonic kidneyMESH:D008171 infection of lung|lung diseasesMESH:D008180 systemic lupus erythematosusMESH:D009103 multiple sclerosisMESH:D011565 psoriasisMESH:D014766 CMV viremiaMESH:D015179 CMV infection increases colonicMESH:D015458 T-cell leukemia virus type-1 mono-infectionMESH:D015658 HIV/HCV-coinfected|Hantaan virus infection|HIV|Virus infection|HIV-1 coinfected|immunodeficiency virus type 1 infectionMESH:D018352 respiratory syndrome coronavirusMESH:D019698 chronic hepatitis C virus infection|chronic hepatitis C|chronic hepatitis C viral infection|chronic hepatitis C virus type 1 infection|acute hepatitis CMESH:D020336 spastic paraparesisMESH:D056486 posttransplant hepatitis c infection|liver damage|hepatitisMESH:D059787 acute virus infectionMESH:D060085 HCV-coinfected
Genetic justification of severe COVID-19 using a rigorous algorithm. Gavriilaki E, et. al. (2021); Clin Immunol; 2021 Apr 09 108726. doi:10.1016/j.clim.2021.108726
Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework. Galmés S, et. al. (2020); Nutrients; 2020 Sep 08 ; 12 (9) . doi:10.3390/nu12092738
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients. Manderstedt E, et. al. (2018); PLoS ONE; 2018; 13(2) 0192024. doi:10.1371/journal.pone.0192024
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Zubiaur P, et. al. (2020); Clin Transl Sci; 2020 Sep 16 . doi:10.1111/cts.12866
Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human. Senapati S, et. al. (2020); J. Genet.; 2020 ; 99
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Mutations and polymorphisms in genes involved in the infections by covid 19: a review. Kaltoum ABO, et. al. (2021); Gene Rep; 2021 Jun ; 23 101062. doi:10.1016/j.genrep.2021.101062
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Will a little change do you good? A putative role of polymorphisms in COVID-19. Paim AAO, et. al. (2021); Immunol Lett; 2021 Apr 23 . doi:10.1016/j.imlet.2021.04.005
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rate. Dutta AK, et. al. (2021); Med Hypotheses; 2021 Feb ; 147 110485. doi:10.1016/j.mehy.2021.110485
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19. Liu D, et. al. (2020); J Infect; 2020 Nov 28 . doi:10.1016/j.jinf.2020.11.031
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies. Lau BT, et. al. (2020); medRxiv; 2020 Nov 04 . doi:10.1101/2020.11.02.20224816
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies. Lau BT, et. al. (2021); Genome Med; 2021 Apr 19 ; 13 (1) 62. doi:10.1186/s13073-021-00882-2
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Zhang Q, et. al. (2020); Science; 2020 10 23 ; 370 (6515) . doi:10.1126/science.abd4570
MESH:C000656865 CIC-PMESH:C000657245 COVID-19 pneumonia|coronavirus disease 2019|SARS-CoV-2 infection|SARS-CoV-2 infections|CoV-2 infection|Covid-19|COVID-19|COVIDMESH:C536767 Blanca GarciaMESH:C537849 NDMESH:C538399 NEMO deficiencyMESH:C566739 dominant deficienciesMESH:D000081207 Primary Immunodeficiencies|Primary Immunodeficiency|Primary Immune DeficiencyMESH:D000163 IrsiCaixa AIDS|139IrsiCaixa AIDSMESH:D000370 ageusiaMESH:D000544 AD disorder|AD TLR3 deficiency|AD TBK1 deficiency|AD deficiencies of TLR3 or AR deficiency|AD TICAM1 deficiency|autosomal-dominant (AD) deficiencies|AD deficiencies|deficiencies or AD TLR3|AD IRF7 deficiencyMESH:D000857 anosmiaMESH:D001102 viral disease|virus infection|viral infectionsMESH:D001327 Autoimmune DiseasesMESH:D003141 Infectious Diseases|Infectious Disease|infectious diseasesMESH:D003333 TRAF3-deficient human embryonic kidneyMESH:D003643 di Brescia|diedMESH:D003920 DiabetesMESH:D004342 AllergyMESH:D004660 virus encephalitis|encephalitisMESH:D005334 feverMESH:D005354 fibrosarcomaMESH:D005862 Palmas de Gran Canaria|Autonoma de BarcelonaMESH:D007153 IRF7 deficiency|Immunodeficiency|UNC-93B deficiency|Immunodeficiencies|immunodeficiency|TLR3 deficiencyMESH:D007239 Infection|silent infection|infections|infection|infected|benign infectionMESH:D007249 inflammationMESH:D008171 Tuberculosis and Lung Diseases|Lung DiseasesMESH:D008661 Inborn Errors|Inborn errors of type I|inborn errors|Inborn errorsMESH:D009080 Kawasaki-like syndromeMESH:D009369 CancerMESH:D011014 pneumonia|pneumonitisMESH:D012128 respiratory distressMESH:D012772 septic shockMESH:D013734 AR IRF7 deficiency impaired|AR IRF7 deficiency|AR IFNAR1 deficiency|autosomal-recessive (AR) deficiencies|AR disorderMESH:D014376 Tuberculosis|tuberculosisMESH:D015499 Functional IRF3 deficiencyMESH:D016638 critical diseaseMESH:D017827 Alessia David21, Joseph LMESH:D020803 simplex encephalitisMESH:D030342 inherited IRF9 deficiency|autosomal recessive and dominant TRIF deficiency|deficiencies) genetic defects|AD genetic disorder|autosomal-recessive or autosomal-dominant deficiencies|genetic defects|inherited TLR3 deficiencyMESH:D053358 X-linked anhidrotic ectodermal dysplasiaOMIM:176500 British Columbia
Host genetic susceptibility to viral infections: the role of type I interferon induction. Bourdon M, et. al. (2020); Genes Immun; 2020 Nov 20 . doi:10.1038/s41435-020-00116-2
A dissection of SARS-CoV2 with clinical implications (Review). Stancioiu F, et. al. (2020); Int. J. Mol. Med.; 2020 Aug ; 46 (2) 489-508. doi:10.3892/ijmm.2020.4636
Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. Hussain M, et. al. (2020); J. Med. Virol.; 2020 Apr 06 . doi:10.1002/jmv.25832
The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues. Darbani B, et. al. (2020); Int J Environ Res Public Health; 2020 05 14 ; 17 (10) . doi:10.3390/ijerph17103433
Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection. Wang J, et. al. (2020); J Gen Virol; 2020 09 ; 101 (9) 921-924. doi:10.1099/jgv.0.001452
An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. Mohammadpour S, et. al. (2020); J. Cell. Physiol.; 2020 Jun 15 . doi:10.1002/jcp.29868
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Ovsyannikova IG, et. al. (2020); Immunol. Rev.; 2020 07 ; 296 (1) 205-219. doi:10.1111/imr.12897
Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2. Fujikura K, et. al. (2020); J. Clin. Pathol.; 2020 Jul 20 . doi:10.1136/jclinpath-2020-206867
A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations. Lee IH, et. al. (2020); Infect Genet Evol; 2020 11 ; 85 104507. doi:10.1016/j.meegid.2020.104507
MESH:C000657245 SARS-CoV-2 infection|Coronavirus disease 2019|novel coronavirus pneumonia|Covid-19|COVID-19MESH:C566236 RS ID Impact AA Change gnomADMESH:D001102 viral infection|virus infectionMESH:D001281 AFMESH:D003643 mortality|deathsMESH:D007239 infectedMESH:D011014 pneumoniaMESH:D011471 prostate and prostate cancer epitheliaMESH:D012131 respiratory failureMESH:D012141 upper respiratory tract infection
ACE2", "polymorphism", "DPP4" and "telemedicine" was conducted on Pubmed and EMBASE till 7th August 2020. RESULT: Possible polymorphisms in ACE2 gene can play a role in influencing the virus entry in host body. Telemedicine can bring a new revolution for medical sector. CONCLUSION: COVID-19 severity is more heinous among diabetic population. So far, the in-silico studies involving human ACE2-viral Spike (S) interaction showed inconsistent predictions regarding some SNPs. But without actual in-vivo studies, a holistic understanding can't be established.">COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine. Sayed S, et. al. (2021); Prim Care Diabetes; 2021 02 ; 15 (1) 4-9. doi:10.1016/j.pcd.2020.08.018
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment. Al-Eitan LN, et. al. (2020); Rev Med Virol; 2020 Nov 17 2194. doi:10.1002/rmv.2194
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry. Ragia G, et. al. (2020); Pharmacogenomics; 2020 Nov 27 . doi:10.2217/pgs-2020-0092
ACE2 partially dictates the host range and tropism of SARS-CoV-2. Gao S, et. al. (2020); Comput Struct Biotechnol J; 2020 Nov 29 . doi:10.1016/j.csbj.2020.11.032
The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies. Waman VP, et. al. (2020); Brief Bioinform; 2020 Dec 22 . doi:10.1093/bib/bbaa362
Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism. Badraoui R, et. al. (2021); Molecules; 2021 Jan 28 ; 26 (3) . doi:10.3390/molecules26030673
Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans. Xue X, et. al. (2021); Sci Rep; 2021 02 04 ; 11 (1) 3187. doi:10.1038/s41598-021-82938-2
Interacting Proteins, Polymorphisms and the Susceptibility of Animals to SARS-CoV-2. Hancock JT, et. al. (2021); Animals (Basel); 2021 Mar 12 ; 11 (3) . doi:10.3390/ani11030797
Genetics Insight for COVID-19 Susceptibility and Severity: A Review. Fricke-Galindo I, et. al. (2021); Front Immunol; 2021 ; 12 622176. doi:10.3389/fimmu.2021.622176
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Al-Mulla F, et. al. (2021); Heliyon; 2021 Feb ; 7 (2) 06133. doi:10.1016/j.heliyon.2021.e06133
Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance. Beaucourt S, et. al. (2014); Curr Opin Virol; 2014 Oct; 810-5. doi:10.1016/j.coviro.2014.04.011
MESH:C000657245 SARS-CoVMESH:C563195 hCoV-EMC coronavirusMESH:C567520 MERS-CoV-infected rhesusMESH:D000361 hypogammaglobulinemiaMESH:D000741 aplastic anemiaMESH:D001117 Genus Type species Arenaviridae ArenavirusMESH:D002044 Bunyavirus San Angelo Hantavirus Hantaan virusMESH:D005334 fever virus|feverMESH:D005536 foot-and-mouth disease virus retains fitnessMESH:D005878 Luis Menendez-AriasMESH:D006470 Congo-haemorrhagic feverMESH:D006479 Crimean-Congo hemorrhagic fever|virus Nairovirus Crimean Congo hemorrhagic fever virus Phlebovirus Rift Valley fever virus|crimean-congo hemorrhagic feverMESH:D006482 hemorrhagic fever virusesMESH:D006526 hepatitis C virus genotype 1-infected|HIV-HCV co-infected|HCV-infected|HCV infected|HIV and hepatitis C virus|hepatitis C virus infectionMESH:D006528 hepatoma|infection of Li23 hepatomaMESH:D007239 rhinovirus infection|RV infectionsMESH:D011565 psoriasisMESH:D015658 Vaccinia virus Retroviridae Lentivirus Human immunodeficiency virus|HIV-infected|virus infectionsMESH:D016751 chronic hepatitis E virus infection|hepatitis E infectionMESH:D018352 coronavirusMESH:D018357 respiratory syncytial virus (RSV) bronchiolitis|respiratory syncytial virus infectionsMESH:D018804 hantavirus pulmonary syndromeMESH:D019698 chronic hepatitis CMESH:D030361 papillomavirus infectionMESH:D053307 coronaviruses (CoV) a hyperMESH:D060085 HIV co-infected
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest. Eskİer D, et. al. (2021); Turk J Biol; 2021 ; 45 (1) 104-113. doi:10.3906/biy-2008-56
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19. Ramos-Lopez O, et. al. (2020); Int J Genomics; 2020 ; 2020 6901217. doi:10.1155/2020/6901217
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Andreano E, et. al. (2021); Cell; 2021 Feb 23 . doi:10.1016/j.cell.2021.02.035
Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection. Jiang C, et. al. (2021); J Pharm Anal; 2021 Mar 26 . doi:10.1016/j.jpha.2021.03.006
MESH:C000657245 covid-19|COVID-2019|SARS-CoV-2 infection|coronavirus disease 2019|Coronavirus disease 2019|Coronavirus Disease 2019|SARS-CoV-2 fitness|COVID-19MESH:D001102 Viral Disease|viral infectionsMESH:D001327 autoimmune diseases|Autoimmune DiseasesMESH:D003643 died of the diseaseMESH:D007153 immunodeficiencyMESH:D007239 Infection|infections|infection|infectedMESH:D011014 Pneumonia|pneumoniaMESH:D012140 respiratory diseaseMESH:D015047 zoonoticMESH:D064420 toxicity
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. Jette CA, et. al. (2021); bioRxiv; 2021 Apr 26 . doi:10.1101/2021.04.23.441195
MESH:C000657245 CoV-2 infection|SARS-CoV-2-Infected|SARS-CoV-2-infected|SARS-CoV-infected|COVID-19|SARS-Related Coronavirus InfectionMESH:D001260 TBS-T Buffer|TBS-TMESH:D003643 MortalityMESH:D003665 VH-VL/CH1-CL elbow bend angleMESH:D004670 CaliforniaMESH:D005597 opennessMESH:D005776 GDMESH:D007239 infection|infectedMESH:D011014 pneumoniaMESH:D012640 fitsMESH:D015047 zoonotic|zoonotic coronavirusMESH:D015658 HIV-1 Clade C InfectionMESH:D018352 Middle East Respiratory SyndromeMESH:D045169 SARS-infected
The Nucleoprotein and Phosphoprotein of Peste des Petits Ruminants Virus Inhibit Interferons Signaling by Blocking the JAK-STAT Pathway. Li P, et. al. (2019); Viruses. 2019 Jul 8;11(7). pii: v11070629. doi: 10.3390/v11070629.
MESH:C000657245 SARS-CoV N proteins|SARS-CoV NMESH:C536108 HeV N proteinsMESH:C536751 WT P proteinsMESH:D001102 viral disease|viral infectionsMESH:D001117 Arenavirus NMESH:D001796 disordered proteinsMESH:D002277 epithelial carcinomaMESH:D003047 Valley virus-infectedMESH:D003141 infectious diseaseMESH:D003967 epidemic diarrhea virus N|Diarrhea Virus NucleocapsidMESH:D005536 Foot-and-mouth disease virus infectionMESH:D007239 mock-infected or infectedMESH:D007674 embryonic kidneyMESH:D008545 melanomaMESH:D008569 N protein also impaired the host IFNMESH:D018352 respiratory syndrome coronavirus (SARS-CoV) NMESH:D030342 disorderedMESH:D045464 Nipah and Hendra Virus|NiV N proteins
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country. Requena D, et. al. (2020); Front Immunol; 2020 ; 11 2008. doi:10.3389/fimmu.2020.02008
MESH:C000657245 covid-19|SARS-CoV-2 infection|coronavirus disease 2019|SARS-CoV-2 infections|2019-nCoV infected|Coronavirus Disease 2019|SARS-CoV infections|COVID-19|COVIDMESH:C537985 IEDB ID|ID ARG BOL BRA CHI COL|IEDB ID ARG BOL BRA CHI COLMESH:C566345 AFNDMESH:D001327 autoimmune diseasesMESH:D001991 Bronchitis Virus StrainMESH:D003141 Infectious DiseasesMESH:D003371 coughMESH:D003643 deathsMESH:D004342 AllergyMESH:D005221 fatigueMESH:D005334 feverMESH:D006973 pressuresMESH:D007239 infections|infected|infectionMESH:D009369 cancerMESH:D011014 pneumoniaMESH:D011565 psoriasisMESH:D012131 respiratory failureMESH:D012140 respiratory diseaseMESH:D012640 fitnessMESH:D015047 zoonoticMESH:D016638 critically illMESH:D018352 Coronavirus disease|CoV infection
Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2. Liu S, et. al. (2020); Front Microbiol; 2020 ; 11 593548. doi:10.3389/fmicb.2020.593548
Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. Miao M, et. al. (2021); Biomedicines; 2021 Apr 11 ; 9 (4) . doi:10.3390/biomedicines9040412
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome. Shikov AE, et. al. (2020); Front Genet; 2020 ; 11 551220. doi:10.3389/fgene.2020.551220
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. Long SW, et. al. (2020); mBio; 2020 Oct 30 ; 11 (6) . doi:10.1128/mBio.02707-20
A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses. Wang Y, et. al. (2020); Cell Res.; 2020 Aug 05 . doi:10.1038/s41422-020-0386-6
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication. von Brunn A, et. al. (2015); Curr Opin Virol; 2015 Oct; 1456-61. doi:10.1016/j.coviro.2015.08.004
- MERS-CoV infectionsMESH:C000657245 CoV|SARS-CoV, HCoV-NL63|HCoV-NL63, HCoV-HKU1, SARS-CoV and MERS-CoV|coronaviruses SARS-CoV, HCoV-NL63|SARS-CoV and MERS-CoV viruses|SARS-CoV|CoV infectionMESH:C537931 pan-CoVMESH:D001102 viral infectionMESH:D002371 Feline CoV (FCoV) serotypes IMESH:D003324 coronary artery diseaseMESH:D003333 SARS-CoV, HCoV-229E|CoV-229E|HCoV-229E-LUC virus-infectedMESH:D006526 HCV infection|hepatitis C virus infectionMESH:D006528 hepatocellular carcinomaMESH:D007239 FCoV infection|infections|infectionMESH:D011014 pneumoniaMESH:D011488 CoV proteinsMESH:D012131 respiratory syndromeMESH:D012141 respiratory tract infections|infection of respiratory and gastrointestinalMESH:D014842 von Hahn|vonMESH:D015658 virus infectionMESH:D016766 Feline Infectious Peritonitis|CoV Feline Infectious Peritonitis VirusMESH:D018352 middle east respiratory syndrome coronavirus infection|middle East respiratory syndrome|coronavirus HKU1|coronavirus|SARS-coronavirus-host|coronavirus infection|Ausbruch von MERS-Coronavirus|Respiratory Syndrome Coronavirus|SARS coronavirus tightlyMESH:D030342 genetic deficiency|Genetic deficiencyMESH:D045169 Coronaviruses post-SARS
Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection. Klaassen K, et. al. (2020); Infect Genet Evol; 2020 10 ; 84 104498. doi:10.1016/j.meegid.2020.104498
MESH:C000657245 covid-19|SARS-CoV-2 infection|SARS-CoV infection|COVID-19MESH:C565965 TSI IBS CEU GBR FIN EAS SAS AFR AMR SRB|TSI IBS FIN GBR CEU EAS SAS AFR AMR PLGMESH:D000077277 esophageal squamous cell carcinomaMESH:D001102 viral diseases|viral infection|viral infectionsMESH:D003141 infectious diseasesMESH:D003550 cystic fibrosisMESH:D003643 mortality|deathMESH:D003922 type I diabetesMESH:D007239 infections|infection|infectedMESH:D009103 multiple sclerosisMESH:D010195 pancreatitisMESH:D011014 pneumoniaMESH:D012120 acute respiratory syndrome|acute respiratory syndrome coronavirus infectionMESH:D012140 respiratory diseaseMESH:D012598 sclerosisMESH:D015658 HIV infection|HIV-1 infection|human diseases or disordersMESH:D016098 GSDMESH:D018352 respiratory syndrome coronavirus infectionMESH:D030342 Mendelian diseasesMESH:D045169 severe acute respiratory syndromeMESH:D055744 invasive aspergillosis
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. Hu J, et. al. (2020); medRxiv; 2020 Nov 09 . doi:10.1101/2020.11.05.20226761
A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Karakas Celik S, et. al. (2020); Int J Immunogenet; 2020 Nov 27 . doi:10.1111/iji.12522
Comparative sequence analysis of full-length genome of FIPV at different tissue passage levels. Phillips JE, et. al. (2013); Virus Genes; 2013 Dec; 47(3) 490-7. doi:10.1007/s11262-013-0972-5
MESH:C000657245 CoV|SARS-CoVMESH:D001102 viral fitnessMESH:D003139 epizootic catarrhal enteritis|ECEMESH:D004283 Canine CoVMESH:D004670 CaliforniaMESH:D005767 gastrointestinal diseaseMESH:D006362 gamma CoV'sMESH:D007154 immune system diseaseMESH:D007239 infections|infectionMESH:D007410 intestinal tropismMESH:D010300 CoV'sMESH:D010534 infectious peritonitis|infectious peritonitis virus infectionMESH:D012131 respiratory syndromeMESH:D012700 serosal membrane damageMESH:D015658 virus infectionMESH:D016766 Feline infectious peritonitis viruses|FIPVMESH:D018352 coronavirus infections|Coronavirus|Coronavirus (CCoV) and type I FCoV|coronavirus spike|coronavirus type I|Feline coronavirus (FCoV) infection|coronavirus type II|coronavirus|coronavirus infection|respiratory syndrome coronavirus openMESH:D064420 cytotoxicity
Myelodysplastic syndrome in a 30-year-old man with coronavirus disease 2019 (COVID-19): a diagnostic challenge. Qing X, et. al. (2021); Autops Case Rep; 2021 Apr 20 ; 11 2021274. doi:10.4322/acr.2021.274
Genomic characterization and evolution of SARS-CoV-2 of a Canadian population. Zhang M, et. al. (2021); PLoS One; 2021 ; 16 (3) 0247799. doi:10.1371/journal.pone.0247799
MESH:C000657245 SARS-CoV-2 infection|COVID-19MESH:D003643 deathsMESH:D006973 pressuresMESH:D007239 Infection|infectionMESH:D007249 inflammationMESH:D011014 Pneumonia|pneumoniaMESH:D012640 fitnessMESH:D018352 coronavirus disease|coronavirus infectionMESH:D058540 AICOMIM:176500 British Columbia
Characterization of the biochemical properties and identification of amino acids forming the catalytic center of 3C-like proteinase of porcine reproductive and respiratory syndrome virus. Xu AT, et. al. (2010); Biotechnol. Lett.; 2010 Dec; 32(12) 1905-10. doi:10.1007/s10529-010-0370-1
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome. Ramlall V, et. al. (2020); medRxiv; 2020 May 13 . doi:10.1101/2020.05.05.20092452
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
Nucleocapsid Interacts with NPM1 and Protects it from Proteolytic Cleavage, Enhancing Cell Survival, and is Involved in PEDV Growth. Shi D, et. al. (2017); Sci Rep; 2017 Jan 03; 739700. doi:10.1038/srep39700
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Gemmati D, et. al. (2020); Int J Mol Sci; 2020 May 14 ; 21 (10) . doi:10.3390/ijms21103474
Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Ghafouri-Fard S, et. al. (2020); Biomed. Pharmacother.; 2020 Aug ; 128 110296. doi:10.1016/j.biopha.2020.110296
ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Asselta R, et. al. (2020); Aging (Albany NY); 2020 06 05 ; 12 (11) 10087-10098. doi:10.18632/aging.103415
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Mollica V, et. al. (2020); Future Oncol; 2020 Jul 13 . doi:10.2217/fon-2020-0571
Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19. Choudhary S, et. al. (2021); Ann Lab Med; 2021 Mar 01 ; 41 (2) 129-138. doi:10.3343/alm.2021.41.2.129
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease. Singh H, et. al. (2020); Microb Pathog; 2020 Dec 02 104621. doi:10.1016/j.micpath.2020.104621
Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level. Kim YC, et. al. (2020); Genes (Basel); 2020 Dec 30 ; 12 (1) . doi:10.3390/genes12010042
The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID-19. Abobaker A, et. al. (2021); J Gene Med; 2021 02 ; 23 (2) 3310. doi:10.1002/jgm.3310
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Hashemi SMA, et. al. (2021); Arch Virol; 2021 May 02 . doi:10.1007/s00705-021-05070-6
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Single cell multiomic profiling of human lung reveals cell type-specific and age-dynamic control of SARS-CoV2 host genes. Wang A, et. al. (2020); Elife; 2020 Nov 09 ; 9. doi:10.7554/eLife.62522
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes. Lopera Maya EA, et. al. (2020); Front Genet; 2020 ; 11 613. doi:10.3389/fgene.2020.00613
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Infectivity and Progression of COVID-19 Based on Selected Host Candidate Gene Variants. Iyer GR, et. al. (2020); Front Genet; 2020 ; 11 861. doi:10.3389/fgene.2020.00861
Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G, et. al. (2020); Life Sci; 2020 Nov 01 ; 260 118313. doi:10.1016/j.lfs.2020.118313